GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Elf1
|
ENSRNOG00000011762 | E74-like factor 1 |
Elf2
|
ENSRNOG00000010815 | E74-like factor 2 |
Etv2
|
ENSRNOG00000024288 | ets variant 2 |
Elf4
|
ENSRNOG00000005352 | E74 like ETS transcription factor 4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Elf1 | rn6_v1_chr15_+_61826711_61826711 | 0.91 | 3.6e-125 | Click! |
Elf4 | rn6_v1_chrX_-_135250519_135250519 | 0.74 | 4.0e-57 | Click! |
Elf2 | rn6_v1_chr2_-_140334912_140334912 | 0.54 | 3.3e-25 | Click! |
Etv2 | rn6_v1_chr1_-_89094530_89094530 | -0.07 | 1.9e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr13_+_89774764 | 208.40 |
ENSRNOT00000005619
|
Arhgap30
|
Rho GTPase activating protein 30 |
chr1_+_198744050 | 182.17 |
ENSRNOT00000024404
|
Itgal
|
integrin subunit alpha L |
chr13_+_50164563 | 170.25 |
ENSRNOT00000029533
|
Lax1
|
lymphocyte transmembrane adaptor 1 |
chr5_-_58987760 | 154.58 |
ENSRNOT00000035040
|
Sit1
|
signaling threshold regulating transmembrane adaptor 1 |
chr10_+_39875371 | 139.70 |
ENSRNOT00000013481
|
Rapgef6
|
Rap guanine nucleotide exchange factor 6 |
chrX_-_71169038 | 134.59 |
ENSRNOT00000005343
|
Il2rg
|
interleukin 2 receptor subunit gamma |
chr4_+_157523320 | 132.61 |
ENSRNOT00000023192
|
Zfp384
|
zinc finger protein 384 |
chr5_+_154522119 | 131.13 |
ENSRNOT00000072618
|
E2f2
|
E2F transcription factor 2 |
chr7_-_107392972 | 126.00 |
ENSRNOT00000093425
|
Tmem71
|
transmembrane protein 71 |
chr13_-_90022269 | 124.21 |
ENSRNOT00000035498
|
Ly9
|
lymphocyte antigen 9 |
chr10_+_11810926 | 120.38 |
ENSRNOT00000036205
ENSRNOT00000036189 |
Nlrc3
|
NLR family, CARD domain containing 3 |
chr10_+_47930633 | 119.93 |
ENSRNOT00000003515
|
Grap
|
GRB2-related adaptor protein |
chr20_+_9948908 | 108.65 |
ENSRNOT00000001541
|
Ubash3a
|
ubiquitin associated and SH3 domain containing, A |
chr20_+_5441876 | 107.24 |
ENSRNOT00000092476
|
Rps18
|
ribosomal protein S18 |
chr11_+_84745904 | 107.11 |
ENSRNOT00000002617
|
Klhl6
|
kelch-like family member 6 |
chr1_+_221448661 | 106.24 |
ENSRNOT00000072493
|
LOC100910252
|
sororin-like |
chr2_+_209097927 | 105.04 |
ENSRNOT00000023807
|
Dennd2d
|
DENN domain containing 2D |
chr20_+_5509059 | 104.11 |
ENSRNOT00000065349
|
Kifc1
|
kinesin family member C1 |
chr5_-_79222687 | 103.01 |
ENSRNOT00000010516
|
Akna
|
AT-hook transcription factor |
chr1_+_198528635 | 100.85 |
ENSRNOT00000022765
|
LOC308990
|
hypothetical protein LOC308990 |
chr10_+_59529785 | 100.03 |
ENSRNOT00000064840
ENSRNOT00000065181 |
Atp2a3
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 |
chr3_-_160730360 | 99.85 |
ENSRNOT00000075864
|
RGD1563818
|
similar to secretory leukocyte protease inhibitor |
chr13_-_55173692 | 99.34 |
ENSRNOT00000064785
ENSRNOT00000029878 ENSRNOT00000029865 ENSRNOT00000060292 ENSRNOT00000000814 |
Ptprc
|
protein tyrosine phosphatase, receptor type, C |
chr20_+_30915213 | 98.65 |
ENSRNOT00000000681
|
Prf1
|
perforin 1 |
chr2_-_190100276 | 98.35 |
ENSRNOT00000015351
|
S100a9
|
S100 calcium binding protein A9 |
chr4_+_34282625 | 98.26 |
ENSRNOT00000011138
ENSRNOT00000086735 |
Glcci1
|
glucocorticoid induced 1 |
chr3_-_160802433 | 97.82 |
ENSRNOT00000076191
|
Slpi
|
secretory leukocyte peptidase inhibitor |
chr1_-_198476476 | 97.52 |
ENSRNOT00000027525
|
Kif22
|
kinesin family member 22 |
chr4_+_157523110 | 96.44 |
ENSRNOT00000081640
|
Zfp384
|
zinc finger protein 384 |
chr15_-_51834030 | 96.17 |
ENSRNOT00000024895
|
Ccar2
|
cell cycle and apoptosis regulator 2 |
chr8_-_49308806 | 94.37 |
ENSRNOT00000047291
|
Cd3e
|
CD3e molecule |
chr1_+_215628785 | 93.95 |
ENSRNOT00000054864
|
Lsp1
|
lymphocyte-specific protein 1 |
chr15_+_45422010 | 93.50 |
ENSRNOT00000012231
|
Rnaseh2b
|
ribonuclease H2, subunit B |
chr14_+_44889287 | 93.08 |
ENSRNOT00000091312
ENSRNOT00000032273 |
Tmem156
|
transmembrane protein 156 |
chrX_+_15155230 | 91.84 |
ENSRNOT00000073289
ENSRNOT00000051439 |
Was
|
Wiskott-Aldrich syndrome |
chr13_-_111917587 | 91.22 |
ENSRNOT00000007649
|
Traf3ip3
|
TRAF3 interacting protein 3 |
chr5_-_140585408 | 90.46 |
ENSRNOT00000018711
|
Cap1
|
adenylate cyclase associated protein 1 |
chr5_+_173460354 | 90.11 |
ENSRNOT00000038747
|
Tnfrsf18
|
TNF receptor superfamily member 18 |
chr3_+_119776925 | 89.97 |
ENSRNOT00000018549
|
Dusp2
|
dual specificity phosphatase 2 |
chrX_+_29157470 | 89.67 |
ENSRNOT00000081986
|
LOC100910245
|
ribose-phosphate pyrophosphokinase 2-like |
chr1_-_197770669 | 88.98 |
ENSRNOT00000023563
|
Lat
|
linker for activation of T cells |
chr3_+_16610086 | 88.92 |
ENSRNOT00000046231
|
LOC100361009
|
rCG64257-like |
chr7_+_120125633 | 88.56 |
ENSRNOT00000012480
|
Sh3bp1
|
SH3-domain binding protein 1 |
chr9_-_9985358 | 88.49 |
ENSRNOT00000080856
|
Crb3
|
crumbs 3, cell polarity complex component |
chr4_+_149957206 | 87.30 |
ENSRNOT00000083843
|
Hnrnpf
|
heterogeneous nuclear ribonucleoprotein F |
chr17_+_43791657 | 87.23 |
ENSRNOT00000074024
|
Hist2h3c2
|
histone cluster 2, H3c2 |
chr10_+_12046541 | 86.15 |
ENSRNOT00000081191
|
Mefv
|
MEFV, pyrin innate immunity regulator |
chr12_-_9331195 | 85.26 |
ENSRNOT00000044134
|
Pan3
|
PAN3 poly(A) specific ribonuclease subunit |
chr4_-_34282351 | 85.18 |
ENSRNOT00000011123
|
Rpa3
|
replication protein A3 |
chr1_-_227441442 | 84.98 |
ENSRNOT00000028433
|
Ms4a1
|
membrane spanning 4-domains A1 |
chr2_+_187218851 | 84.39 |
ENSRNOT00000017798
|
Sh2d2a
|
SH2 domain containing 2A |
chr4_-_113866674 | 84.28 |
ENSRNOT00000010020
|
Dok1
|
docking protein 1 |
chr13_+_90759260 | 83.16 |
ENSRNOT00000010551
|
Pigm
|
phosphatidylinositol glycan anchor biosynthesis, class M |
chr10_-_94500591 | 82.77 |
ENSRNOT00000015976
|
Cd79b
|
CD79b molecule |
chr20_+_3875706 | 82.43 |
ENSRNOT00000036900
|
RT1-Ha
|
RT1 class II, locus Ha |
chr13_+_51958834 | 82.11 |
ENSRNOT00000007833
|
Ptpn7
|
protein tyrosine phosphatase, non-receptor type 7 |
chrX_+_70461718 | 81.99 |
ENSRNOT00000078233
ENSRNOT00000003789 |
Kif4a
|
kinesin family member 4A |
chr8_-_49280901 | 81.83 |
ENSRNOT00000021390
|
Cd3g
|
CD3g molecule |
chr7_-_94774569 | 81.71 |
ENSRNOT00000036399
|
Dscc1
|
DNA replication and sister chromatid cohesion 1 |
chr20_+_4020317 | 80.87 |
ENSRNOT00000000526
|
RT1-DOb
|
RT1 class II, locus DOb |
chr7_+_70614617 | 80.58 |
ENSRNOT00000035382
|
Arhgap9
|
Rho GTPase activating protein 9 |
chr2_+_183674522 | 79.82 |
ENSRNOT00000014433
|
Tmem154
|
transmembrane protein 154 |
chr4_+_152892599 | 79.53 |
ENSRNOT00000079090
|
Kdm5a
|
lysine demethylase 5A |
chr14_-_71814523 | 79.14 |
ENSRNOT00000004094
|
Bst1
|
bone marrow stromal cell antigen 1 |
chr19_+_25077918 | 78.98 |
ENSRNOT00000006964
|
Asf1b
|
anti-silencing function 1B histone chaperone |
chr12_+_2180150 | 78.17 |
ENSRNOT00000001322
|
Stxbp2
|
syntaxin binding protein 2 |
chr1_+_81779380 | 77.94 |
ENSRNOT00000065865
ENSRNOT00000080143 ENSRNOT00000089592 ENSRNOT00000080840 |
Arhgef1
|
Rho guanine nucleotide exchange factor 1 |
chr5_-_76756140 | 77.67 |
ENSRNOT00000022107
ENSRNOT00000089251 |
Ptbp3
|
polypyrimidine tract binding protein 3 |
chr10_+_12046701 | 77.56 |
ENSRNOT00000011073
ENSRNOT00000084004 |
Mefv
|
MEFV, pyrin innate immunity regulator |
chr5_-_147761983 | 77.51 |
ENSRNOT00000012936
|
Lck
|
LCK proto-oncogene, Src family tyrosine kinase |
chr11_-_54404612 | 77.27 |
ENSRNOT00000033837
|
RGD1310335
|
similar to RIKEN cDNA C330027C09 |
chr2_+_52333396 | 76.93 |
ENSRNOT00000046174
|
RGD1306227
|
similar to 4833420G17Rik protein |
chr1_-_219438779 | 76.57 |
ENSRNOT00000029237
|
Tbc1d10c
|
TBC1 domain family, member 10C |
chr6_-_141147264 | 74.96 |
ENSRNOT00000042900
|
LOC100361105
|
Igh protein-like |
chr1_+_242959488 | 74.47 |
ENSRNOT00000015668
|
Dock8
|
dedicator of cytokinesis 8 |
chr17_-_76410294 | 74.13 |
ENSRNOT00000023892
|
Nudt5
|
nudix hydrolase 5 |
chr10_-_30118873 | 74.04 |
ENSRNOT00000006063
|
Ublcp1
|
ubiquitin-like domain containing CTD phosphatase 1 |
chr1_-_213907144 | 73.86 |
ENSRNOT00000054874
|
Sigirr
|
single Ig and TIR domain containing |
chr6_-_36940868 | 73.75 |
ENSRNOT00000006470
|
Gen1
|
GEN1 Holliday junction 5' flap endonuclease |
chr7_-_119797098 | 72.85 |
ENSRNOT00000009994
|
Rac2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr14_-_86796378 | 72.31 |
ENSRNOT00000092021
|
Myo1g
|
myosin IG |
chr17_-_78812111 | 72.24 |
ENSRNOT00000021506
|
Dclre1c
|
DNA cross-link repair 1C |
chr13_+_83996080 | 72.24 |
ENSRNOT00000004403
ENSRNOT00000070958 |
Cd247
|
Cd247 molecule |
chr3_-_160739137 | 72.19 |
ENSRNOT00000075836
|
Slpil2
|
antileukoproteinase-like 2 |
chr5_-_147803851 | 72.08 |
ENSRNOT00000071922
|
Eif3i
|
eukaryotic translation initiation factor 3, subunit I |
chrX_+_134979646 | 72.01 |
ENSRNOT00000006035
|
Sash3
|
SAM and SH3 domain containing 3 |
chr4_-_157263890 | 70.77 |
ENSRNOT00000065416
|
Ptpn6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr6_+_109562587 | 70.13 |
ENSRNOT00000011563
|
Batf
|
basic leucine zipper ATF-like transcription factor |
chr3_-_160738927 | 69.91 |
ENSRNOT00000043470
|
Slpil2
|
antileukoproteinase-like 2 |
chr11_-_54514441 | 69.82 |
ENSRNOT00000002673
|
Retnlg
|
resistin-like gamma |
chr1_-_89473904 | 69.66 |
ENSRNOT00000089474
|
Fxyd5
|
FXYD domain-containing ion transport regulator 5 |
chr3_+_159995064 | 69.18 |
ENSRNOT00000012606
|
Ttpal
|
alpha tocopherol transfer protein like |
chr7_+_95309928 | 69.16 |
ENSRNOT00000005887
|
Mtbp
|
MDM2 binding protein |
chr4_+_152892388 | 69.14 |
ENSRNOT00000056198
ENSRNOT00000090218 ENSRNOT00000075895 |
Kdm5a
|
lysine demethylase 5A |
chr5_+_142845114 | 68.27 |
ENSRNOT00000039870
|
Yrdc
|
yrdC N(6)-threonylcarbamoyltransferase domain containing |
chr10_+_56187679 | 67.91 |
ENSRNOT00000085115
|
Tp53
|
tumor protein p53 |
chr14_-_69927938 | 66.76 |
ENSRNOT00000058838
|
Ncapg
|
non-SMC condensin I complex, subunit G |
chr12_+_13716596 | 66.42 |
ENSRNOT00000080216
|
Actb
|
actin, beta |
chr16_-_21380331 | 66.07 |
ENSRNOT00000015247
|
Atp13a1
|
ATPase 13A1 |
chr8_-_71533069 | 65.91 |
ENSRNOT00000021863
|
Trip4
|
thyroid hormone receptor interactor 4 |
chr20_-_4863198 | 65.78 |
ENSRNOT00000001108
|
Ltb
|
lymphotoxin beta |
chr11_-_87628502 | 65.46 |
ENSRNOT00000002568
|
Med15
|
mediator complex subunit 15 |
chr7_+_119482272 | 65.07 |
ENSRNOT00000009544
|
Ncf4
|
neutrophil cytosolic factor 4 |
chr2_+_212257225 | 65.00 |
ENSRNOT00000077883
|
Vav3
|
vav guanine nucleotide exchange factor 3 |
chr10_-_104054805 | 64.68 |
ENSRNOT00000004853
|
Nt5c
|
5', 3'-nucleotidase, cytosolic |
chr3_+_28627084 | 64.49 |
ENSRNOT00000049884
|
Arhgap15
|
Rho GTPase activating protein 15 |
chr11_-_66759402 | 64.45 |
ENSRNOT00000003326
|
Hcls1
|
hematopoietic cell specific Lyn substrate 1 |
chr17_+_43734461 | 64.45 |
ENSRNOT00000072564
|
Hist1h1d
|
histone cluster 1, H1d |
chr1_-_198225580 | 64.44 |
ENSRNOT00000026909
|
Ppp4c
|
protein phosphatase 4, catalytic subunit |
chr16_-_7588841 | 64.44 |
ENSRNOT00000084645
|
Mettl6
|
methyltransferase like 6 |
chr14_-_18849258 | 64.36 |
ENSRNOT00000033406
|
Pf4
|
platelet factor 4 |
chr8_+_115131367 | 63.80 |
ENSRNOT00000014849
|
Rpl29
|
ribosomal protein L29 |
chr13_+_98615287 | 63.41 |
ENSRNOT00000004032
|
Itpkb
|
inositol-trisphosphate 3-kinase B |
chr3_+_110618298 | 63.08 |
ENSRNOT00000012454
|
Knstrn
|
kinetochore-localized astrin/SPAG5 binding protein |
chr4_-_78342863 | 62.97 |
ENSRNOT00000049038
|
Gimap6
|
GTPase, IMAP family member 6 |
chr1_-_198577226 | 62.66 |
ENSRNOT00000055013
|
Spn
|
sialophorin |
chr3_+_148327965 | 61.77 |
ENSRNOT00000010851
ENSRNOT00000088481 |
Tpx2
|
TPX2, microtubule nucleation factor |
chr1_+_81230989 | 61.75 |
ENSRNOT00000077952
|
Kcnn4
|
potassium calcium-activated channel subfamily N member 4 |
chr17_+_22984844 | 61.41 |
ENSRNOT00000078310
|
Nedd9
|
neural precursor cell expressed, developmentally down-regulated 9 |
chr3_-_14643897 | 61.35 |
ENSRNOT00000082008
ENSRNOT00000025983 |
Ggta1
|
glycoprotein, alpha-galactosyltransferase 1 |
chr10_+_94566928 | 61.25 |
ENSRNOT00000078446
|
Prr29
|
proline rich 29 |
chr7_+_125288081 | 61.19 |
ENSRNOT00000085216
|
Parvg
|
parvin, gamma |
chr20_+_5184515 | 61.02 |
ENSRNOT00000089411
|
LOC103694381
|
lymphotoxin-beta |
chr2_-_187909394 | 60.94 |
ENSRNOT00000032355
|
Rab25
|
RAB25, member RAS oncogene family |
chr1_-_225952516 | 60.78 |
ENSRNOT00000043387
|
Incenp
|
inner centromere protein |
chr6_-_142585188 | 60.30 |
ENSRNOT00000067437
|
AABR07065815.1
|
|
chr18_+_86299463 | 60.06 |
ENSRNOT00000058152
|
Cd226
|
CD226 molecule |
chr3_+_72395218 | 59.64 |
ENSRNOT00000057616
|
Prg3
|
proteoglycan 3, pro eosinophil major basic protein 2 |
chr9_+_65620658 | 59.25 |
ENSRNOT00000084498
|
Casp8
|
caspase 8 |
chr8_+_117355943 | 59.14 |
ENSRNOT00000027318
|
Dalrd3
|
DALR anticodon binding domain containing 3 |
chr19_+_37652969 | 58.99 |
ENSRNOT00000041970
|
Carmil2
|
capping protein regulator and myosin 1 linker 2 |
chr9_-_92616165 | 58.88 |
ENSRNOT00000056995
|
Sp110
|
SP110 nuclear body protein |
chr10_+_106856097 | 58.69 |
ENSRNOT00000072387
|
Birc5
|
baculoviral IAP repeat-containing 5 |
chr3_+_1478525 | 58.66 |
ENSRNOT00000008161
|
Psd4
|
pleckstrin and Sec7 domain containing 4 |
chr5_-_118541928 | 58.57 |
ENSRNOT00000012947
|
Itgb3bp
|
integrin subunit beta 3 binding protein |
chr16_+_73584521 | 58.46 |
ENSRNOT00000024301
|
Gins4
|
GINS complex subunit 4 |
chr4_-_115354795 | 58.34 |
ENSRNOT00000017691
|
Cd207
|
CD207 molecule |
chr18_-_28535828 | 58.33 |
ENSRNOT00000068386
|
Tmem173
|
transmembrane protein 173 |
chr7_+_70612103 | 58.25 |
ENSRNOT00000057833
|
Arhgap9
|
Rho GTPase activating protein 9 |
chr4_+_69384145 | 58.16 |
ENSRNOT00000084834
|
Trbv13-2
|
T cell receptor beta, variable 13-2 |
chr12_-_11265865 | 57.88 |
ENSRNOT00000001315
|
Arpc1b
|
actin related protein 2/3 complex, subunit 1B |
chr1_+_219403970 | 57.82 |
ENSRNOT00000029607
|
Ptprcap
|
protein tyrosine phosphatase, receptor type, C-associated protein |
chr8_+_11888591 | 57.75 |
ENSRNOT00000083967
|
Ccdc82
|
coiled-coil domain containing 82 |
chr15_-_29443454 | 57.72 |
ENSRNOT00000082167
|
AABR07017635.2
|
|
chr9_-_17835240 | 57.68 |
ENSRNOT00000026988
|
Nfkbie
|
NFKB inhibitor epsilon |
chr17_+_44763598 | 57.56 |
ENSRNOT00000079880
|
Hist1h3b
|
histone cluster 1, H3b |
chr15_+_32614002 | 57.28 |
ENSRNOT00000072962
|
AABR07017902.1
|
|
chr2_-_241545250 | 56.87 |
ENSRNOT00000073875
|
Bank1
|
B-cell scaffold protein with ankyrin repeats 1 |
chr6_-_139041812 | 56.83 |
ENSRNOT00000074510
|
AABR07065656.1
|
|
chr3_+_152909189 | 56.73 |
ENSRNOT00000066341
|
Tgif2
|
TGFB-induced factor homeobox 2 |
chr15_+_31989041 | 56.69 |
ENSRNOT00000073686
|
AABR07017868.2
|
|
chr4_+_101645731 | 56.10 |
ENSRNOT00000087901
|
AABR07060953.1
|
|
chr15_-_29465807 | 56.08 |
ENSRNOT00000075046
|
AABR07017635.1
|
|
chr8_-_71118927 | 55.56 |
ENSRNOT00000042633
|
Plekho2
|
pleckstrin homology domain containing O2 |
chr11_+_85508300 | 55.13 |
ENSRNOT00000038646
|
AABR07034730.3
|
|
chr10_+_56576428 | 55.04 |
ENSRNOT00000079237
ENSRNOT00000023291 |
Cldn7
|
claudin 7 |
chr1_-_199439210 | 54.67 |
ENSRNOT00000026699
|
Pycard
|
PYD and CARD domain containing |
chr15_-_70399924 | 54.60 |
ENSRNOT00000087940
|
Diaph3
|
diaphanous-related formin 3 |
chr3_+_7635933 | 54.26 |
ENSRNOT00000061029
|
Ttf1
|
transcription termination factor 1 |
chr7_+_145068286 | 54.20 |
ENSRNOT00000088956
ENSRNOT00000065753 |
Nckap1l
|
NCK associated protein 1 like |
chr4_+_69138525 | 54.13 |
ENSRNOT00000073589
|
Trbv1
|
T cell receptor beta, variable 1 |
chr1_-_265798167 | 54.08 |
ENSRNOT00000079483
|
Ldb1
|
LIM domain binding 1 |
chr10_-_87067456 | 54.01 |
ENSRNOT00000014163
|
Ccr7
|
C-C motif chemokine receptor 7 |
chr17_+_44556039 | 53.73 |
ENSRNOT00000086540
|
Prss16
|
protease, serine 16 |
chr1_-_47502952 | 53.67 |
ENSRNOT00000025580
|
Tagap
|
T-cell activation RhoGTPase activating protein |
chr3_+_112531703 | 53.64 |
ENSRNOT00000041727
|
LOC100911204
|
protein CASC5-like |
chr1_-_100559942 | 53.57 |
ENSRNOT00000026862
|
Nr1h2
|
nuclear receptor subfamily 1, group H, member 2 |
chr17_+_43632397 | 53.36 |
ENSRNOT00000013790
|
Hist1h2ah
|
histone cluster 1, H2ah |
chr9_+_10952374 | 53.24 |
ENSRNOT00000074993
|
Lrg1
|
leucine-rich alpha-2-glycoprotein 1 |
chr1_-_198128857 | 53.20 |
ENSRNOT00000026496
|
Coro1a
|
coronin 1A |
chr1_+_189550354 | 53.09 |
ENSRNOT00000083153
|
Exnef
|
exonuclease NEF-sp |
chr1_-_142020525 | 53.08 |
ENSRNOT00000042558
|
Cib1
|
calcium and integrin binding 1 |
chr2_-_196323881 | 53.04 |
ENSRNOT00000028642
|
Tnfaip8l2
|
TNF alpha induced protein 8 like 2 |
chr10_-_70341837 | 52.92 |
ENSRNOT00000077261
|
Slfn13
|
schlafen family member 13 |
chr13_-_108178609 | 52.89 |
ENSRNOT00000004525
|
Cenpf
|
centromere protein F |
chr8_+_99625545 | 52.87 |
ENSRNOT00000010689
ENSRNOT00000056727 |
Plscr1
|
phospholipid scramblase 1 |
chr13_+_90116843 | 52.87 |
ENSRNOT00000006306
|
Cd48
|
Cd48 molecule |
chr4_+_118167294 | 52.53 |
ENSRNOT00000022367
|
LOC687679
|
similar to small nuclear ribonucleoprotein polypeptide G |
chr14_-_43992587 | 52.39 |
ENSRNOT00000003425
|
Rhoh
|
ras homolog family member H |
chr4_+_100209951 | 52.31 |
ENSRNOT00000015807
|
LOC691113
|
hypothetical protein LOC691113 |
chr15_+_30785248 | 52.26 |
ENSRNOT00000089085
|
AABR07017768.5
|
|
chr15_-_30323833 | 52.09 |
ENSRNOT00000071631
|
AABR07017714.1
|
|
chr4_+_99239115 | 51.92 |
ENSRNOT00000009515
|
Cd8a
|
CD8a molecule |
chr2_+_219628695 | 51.75 |
ENSRNOT00000067324
|
Sass6
|
SAS-6 centriolar assembly protein |
chr9_+_65614142 | 51.67 |
ENSRNOT00000016613
|
Casp8
|
caspase 8 |
chr16_-_48921242 | 51.63 |
ENSRNOT00000041596
|
Cenpu
|
centromere protein U |
chr7_+_126736732 | 51.39 |
ENSRNOT00000022012
|
Gtse1
|
G-2 and S-phase expressed 1 |
chr6_-_9459188 | 51.37 |
ENSRNOT00000019894
|
Srbd1
|
S1 RNA binding domain 1 |
chr13_-_89606326 | 51.32 |
ENSRNOT00000029179
|
Fcer1g
|
Fc fragment of IgE receptor Ig |
chr8_-_61823102 | 50.94 |
ENSRNOT00000058645
|
Neil1
|
nei-like DNA glycosylase 1 |
chr20_+_5040337 | 50.52 |
ENSRNOT00000068435
|
Clic1
|
chloride intracellular channel 1 |
chr20_-_4070721 | 50.36 |
ENSRNOT00000000523
|
RT1-Ba
|
RT1 class II, locus Ba |
chr5_-_57683932 | 50.22 |
ENSRNOT00000074796
|
Dcaf12
|
DDB1 and CUL4 associated factor 12 |
chr8_-_33661049 | 50.21 |
ENSRNOT00000068037
|
Fli1
|
Fli-1 proto-oncogene, ETS transcription factor |
chr1_+_189549960 | 50.19 |
ENSRNOT00000019654
|
Exnef
|
exonuclease NEF-sp |
chr1_-_20417637 | 50.16 |
ENSRNOT00000036049
|
RGD1559962
|
similar to High mobility group protein 2 (HMG-2) |
chr16_-_9430743 | 50.14 |
ENSRNOT00000043811
|
Wdfy4
|
WDFY family member 4 |
chr19_-_39087880 | 50.04 |
ENSRNOT00000070822
|
Chtf8
|
chromosome transmission fidelity factor 8 |
chr2_-_189573280 | 50.02 |
ENSRNOT00000022897
|
Rps27
|
ribosomal protein S27 |
chr18_+_27657628 | 49.98 |
ENSRNOT00000026303
|
Egr1
|
early growth response 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
55.7 | 278.4 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
49.6 | 148.7 | GO:1901726 | negative regulation of histone deacetylase activity(GO:1901726) |
44.2 | 176.8 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
32.8 | 98.4 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
32.6 | 97.8 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
31.2 | 93.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
30.2 | 151.0 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
29.0 | 260.7 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
28.3 | 85.0 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
28.1 | 84.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
28.0 | 307.5 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
27.9 | 111.4 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
27.7 | 110.9 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
27.2 | 108.7 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
26.6 | 106.5 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
26.1 | 52.2 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
25.6 | 76.9 | GO:0042531 | regulation of tyrosine phosphorylation of STAT protein(GO:0042509) positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
25.5 | 255.1 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
25.3 | 151.6 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
25.2 | 100.9 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
25.1 | 25.1 | GO:0060101 | negative regulation of phagocytosis, engulfment(GO:0060101) |
24.9 | 373.4 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
24.7 | 148.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
24.0 | 96.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
23.9 | 286.3 | GO:0001771 | immunological synapse formation(GO:0001771) |
23.6 | 70.8 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
22.9 | 91.7 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
22.5 | 67.6 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
22.5 | 67.6 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
22.3 | 44.7 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
22.3 | 67.0 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
22.1 | 22.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
22.1 | 66.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
21.3 | 63.8 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
21.2 | 63.7 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
21.1 | 63.4 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
21.1 | 63.3 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
21.0 | 21.0 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
21.0 | 63.1 | GO:0002149 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
21.0 | 21.0 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
20.4 | 61.3 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
20.2 | 100.8 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
20.1 | 100.5 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
20.1 | 80.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
20.0 | 60.1 | GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
19.8 | 178.2 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
19.7 | 19.7 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
19.6 | 195.6 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
19.1 | 57.4 | GO:1904586 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) |
19.0 | 190.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
18.9 | 37.9 | GO:0002326 | B cell lineage commitment(GO:0002326) |
18.5 | 55.6 | GO:1905218 | cellular response to astaxanthin(GO:1905218) |
18.4 | 55.1 | GO:0045575 | basophil activation(GO:0045575) |
18.1 | 54.3 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
17.9 | 17.9 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
17.9 | 71.6 | GO:2000814 | positive regulation of barbed-end actin filament capping(GO:2000814) |
17.4 | 69.5 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
17.4 | 52.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
17.2 | 17.2 | GO:0034418 | urate biosynthetic process(GO:0034418) |
17.1 | 51.2 | GO:1904882 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
17.0 | 85.0 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
17.0 | 84.8 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
16.9 | 33.9 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
16.9 | 16.9 | GO:0002434 | immune complex clearance(GO:0002434) |
16.9 | 33.8 | GO:0006308 | DNA catabolic process(GO:0006308) |
16.9 | 84.3 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
16.8 | 50.5 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
16.6 | 99.8 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
16.5 | 49.6 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
16.2 | 32.4 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
16.2 | 64.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
16.1 | 64.6 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
16.0 | 47.9 | GO:0019417 | sulfur oxidation(GO:0019417) |
15.9 | 47.8 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
15.9 | 47.7 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
15.9 | 31.8 | GO:0019323 | pentose catabolic process(GO:0019323) |
15.9 | 79.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
15.9 | 47.6 | GO:1905132 | metaphase/anaphase transition of meiotic cell cycle(GO:0044785) regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902102) negative regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902103) regulation of meiotic chromosome separation(GO:1905132) negative regulation of meiotic chromosome separation(GO:1905133) |
15.7 | 62.8 | GO:0034240 | negative regulation of macrophage fusion(GO:0034240) |
15.6 | 77.8 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
15.6 | 46.7 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
15.4 | 92.4 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
15.4 | 46.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
15.4 | 46.1 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
15.2 | 60.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
15.1 | 30.3 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
15.0 | 105.0 | GO:0051256 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
15.0 | 74.8 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
14.9 | 44.6 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
14.9 | 44.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
14.8 | 399.5 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
14.7 | 58.9 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
14.7 | 58.6 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
14.6 | 29.2 | GO:0002654 | regulation of tolerance induction dependent upon immune response(GO:0002652) positive regulation of tolerance induction dependent upon immune response(GO:0002654) |
14.5 | 43.4 | GO:1904170 | regulation of bleb assembly(GO:1904170) |
14.4 | 43.3 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
14.4 | 100.5 | GO:0070269 | pyroptosis(GO:0070269) |
14.3 | 185.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
14.2 | 56.8 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
14.1 | 42.2 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
14.0 | 42.1 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
13.7 | 68.3 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
13.5 | 53.9 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
13.4 | 53.7 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
13.4 | 93.7 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
13.4 | 40.1 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
13.4 | 40.1 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
13.2 | 105.5 | GO:0016584 | nucleosome positioning(GO:0016584) |
13.1 | 39.4 | GO:1902963 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
13.1 | 26.3 | GO:0071283 | cellular response to iron(III) ion(GO:0071283) |
13.1 | 52.5 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
13.1 | 104.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
13.1 | 26.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
13.0 | 39.1 | GO:0046967 | cytosol to ER transport(GO:0046967) peptide antigen transport(GO:0046968) |
13.0 | 52.1 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
13.0 | 39.0 | GO:0021997 | neural plate axis specification(GO:0021997) |
12.8 | 64.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
12.8 | 51.1 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
12.7 | 38.0 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
12.6 | 113.6 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
12.6 | 37.8 | GO:1901227 | negative regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901227) |
12.5 | 50.2 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
12.5 | 25.0 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
12.5 | 75.0 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
12.4 | 37.2 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
12.1 | 48.5 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
12.1 | 48.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
12.0 | 48.1 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
12.0 | 12.0 | GO:0044253 | positive regulation of multicellular organismal metabolic process(GO:0044253) |
12.0 | 23.9 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
12.0 | 35.9 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
11.9 | 155.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
11.8 | 58.9 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
11.7 | 151.7 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
11.6 | 11.6 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
11.6 | 34.8 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
11.6 | 197.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
11.6 | 138.8 | GO:0043249 | erythrocyte maturation(GO:0043249) |
11.6 | 80.9 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
11.5 | 23.0 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
11.4 | 34.2 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
11.4 | 11.4 | GO:0030221 | basophil differentiation(GO:0030221) |
11.3 | 283.3 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
11.3 | 45.2 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
11.2 | 56.0 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
11.2 | 22.4 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
11.1 | 55.5 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
11.1 | 55.5 | GO:0007144 | female meiosis I(GO:0007144) |
11.1 | 11.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
11.0 | 33.1 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
10.9 | 32.8 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
10.9 | 87.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
10.8 | 32.4 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
10.7 | 75.1 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
10.7 | 10.7 | GO:0002339 | B cell selection(GO:0002339) |
10.7 | 21.4 | GO:1902751 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
10.6 | 31.9 | GO:0014739 | positive regulation of muscle hyperplasia(GO:0014739) |
10.6 | 31.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
10.6 | 84.7 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
10.6 | 116.1 | GO:0002467 | germinal center formation(GO:0002467) |
10.5 | 10.5 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
10.5 | 21.0 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
10.5 | 21.0 | GO:0002344 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
10.5 | 21.0 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
10.5 | 31.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
10.4 | 62.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
10.4 | 103.9 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
10.4 | 62.2 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
10.4 | 93.3 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
10.3 | 93.0 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
10.3 | 10.3 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
10.2 | 50.8 | GO:0032202 | telomere assembly(GO:0032202) |
10.1 | 50.7 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
10.1 | 70.7 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
10.1 | 120.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
10.1 | 30.2 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
10.0 | 29.9 | GO:0021747 | cochlear nucleus development(GO:0021747) |
9.9 | 168.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
9.9 | 9.9 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
9.9 | 9.9 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
9.9 | 88.8 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
9.8 | 275.6 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
9.8 | 59.0 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
9.8 | 29.5 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
9.8 | 19.6 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
9.7 | 29.2 | GO:0030578 | PML body organization(GO:0030578) |
9.7 | 29.1 | GO:0071461 | cellular response to redox state(GO:0071461) |
9.7 | 38.7 | GO:0042256 | mature ribosome assembly(GO:0042256) |
9.6 | 28.9 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
9.5 | 37.9 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
9.4 | 131.1 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
9.3 | 74.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
9.3 | 18.7 | GO:2000464 | positive regulation of astrocyte chemotaxis(GO:2000464) |
9.3 | 9.3 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
9.3 | 27.9 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
9.3 | 18.6 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
9.3 | 27.9 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
9.3 | 37.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
9.2 | 295.3 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
9.2 | 36.8 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
9.1 | 36.6 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
9.1 | 36.5 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
9.0 | 27.0 | GO:0060490 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
9.0 | 71.9 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
8.9 | 17.8 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
8.9 | 8.9 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
8.9 | 44.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
8.8 | 17.7 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
8.7 | 96.2 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
8.7 | 26.2 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) |
8.7 | 43.6 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
8.7 | 26.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
8.7 | 26.1 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
8.7 | 34.8 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
8.7 | 26.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
8.5 | 17.1 | GO:0001806 | type IV hypersensitivity(GO:0001806) regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
8.5 | 162.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
8.5 | 25.6 | GO:0002777 | antimicrobial peptide biosynthetic process(GO:0002777) antibacterial peptide biosynthetic process(GO:0002780) |
8.5 | 25.6 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
8.5 | 498.8 | GO:0070527 | platelet aggregation(GO:0070527) |
8.3 | 24.9 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
8.2 | 33.0 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
8.2 | 16.4 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
8.2 | 98.4 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
8.2 | 49.2 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
8.2 | 24.6 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
8.2 | 89.8 | GO:0002360 | T cell lineage commitment(GO:0002360) |
8.1 | 276.1 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
8.1 | 64.8 | GO:0030259 | lipid glycosylation(GO:0030259) |
8.1 | 24.3 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
8.1 | 16.1 | GO:0046864 | isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
8.1 | 16.1 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
8.0 | 32.2 | GO:0042148 | strand invasion(GO:0042148) |
8.0 | 56.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
8.0 | 48.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
7.9 | 15.9 | GO:0043366 | beta selection(GO:0043366) |
7.9 | 87.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
7.9 | 47.7 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
7.9 | 31.7 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
7.9 | 94.8 | GO:0006265 | DNA topological change(GO:0006265) |
7.8 | 109.8 | GO:0042832 | defense response to protozoan(GO:0042832) |
7.8 | 172.5 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
7.8 | 47.0 | GO:0071763 | nuclear membrane organization(GO:0071763) |
7.8 | 15.6 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
7.8 | 54.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
7.8 | 23.3 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
7.8 | 15.5 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
7.7 | 46.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
7.7 | 61.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
7.7 | 69.3 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
7.7 | 23.0 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
7.7 | 23.0 | GO:0003162 | atrioventricular node development(GO:0003162) |
7.6 | 137.5 | GO:0031297 | replication fork processing(GO:0031297) |
7.5 | 346.7 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
7.5 | 30.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
7.5 | 15.0 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) |
7.4 | 7.4 | GO:0033045 | regulation of sister chromatid segregation(GO:0033045) |
7.4 | 14.7 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
7.4 | 7.4 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
7.3 | 36.7 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
7.3 | 29.3 | GO:0097681 | double-strand break repair via alternative nonhomologous end joining(GO:0097681) |
7.3 | 29.3 | GO:0002084 | protein depalmitoylation(GO:0002084) |
7.3 | 14.5 | GO:0080144 | amino acid homeostasis(GO:0080144) |
7.3 | 14.5 | GO:0048254 | snoRNA localization(GO:0048254) |
7.2 | 21.7 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
7.2 | 21.7 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
7.2 | 21.7 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
7.2 | 14.4 | GO:1902211 | regulation of prolactin signaling pathway(GO:1902211) |
7.2 | 57.5 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
7.2 | 42.9 | GO:0080009 | mRNA methylation(GO:0080009) |
7.1 | 21.3 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
7.1 | 14.1 | GO:0032258 | CVT pathway(GO:0032258) |
7.0 | 21.1 | GO:0030043 | actin filament fragmentation(GO:0030043) |
7.0 | 28.1 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
7.0 | 7.0 | GO:0061741 | vacuolar transmembrane transport(GO:0034486) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) |
7.0 | 21.0 | GO:0021764 | amygdala development(GO:0021764) |
7.0 | 27.9 | GO:0007296 | vitellogenesis(GO:0007296) |
7.0 | 7.0 | GO:0035261 | external genitalia morphogenesis(GO:0035261) |
6.9 | 48.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
6.9 | 172.1 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
6.9 | 20.6 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
6.9 | 109.7 | GO:0048242 | epinephrine secretion(GO:0048242) |
6.9 | 68.6 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
6.8 | 41.1 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
6.8 | 27.3 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
6.8 | 34.0 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
6.8 | 27.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
6.8 | 20.4 | GO:0036446 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
6.8 | 13.6 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
6.8 | 20.3 | GO:0036334 | epidermal stem cell homeostasis(GO:0036334) |
6.8 | 33.8 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
6.7 | 33.6 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
6.7 | 26.9 | GO:0009826 | unidimensional cell growth(GO:0009826) |
6.6 | 53.1 | GO:1903232 | melanosome assembly(GO:1903232) |
6.6 | 6.6 | GO:0002584 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
6.6 | 53.0 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
6.6 | 6.6 | GO:0071865 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
6.6 | 6.6 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
6.5 | 6.5 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
6.5 | 58.3 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
6.5 | 6.5 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
6.5 | 6.5 | GO:0071220 | response to bacterial lipoprotein(GO:0032493) response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) |
6.5 | 38.8 | GO:0070827 | chromatin maintenance(GO:0070827) |
6.5 | 12.9 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
6.5 | 25.8 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
6.4 | 19.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
6.4 | 25.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
6.4 | 19.3 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
6.4 | 96.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
6.4 | 6.4 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
6.4 | 6.4 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
6.4 | 12.8 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
6.4 | 38.2 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
6.3 | 76.1 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
6.3 | 19.0 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
6.3 | 6.3 | GO:0009597 | detection of virus(GO:0009597) |
6.3 | 81.3 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
6.2 | 31.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
6.2 | 6.2 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
6.2 | 37.0 | GO:0051026 | chiasma assembly(GO:0051026) |
6.2 | 24.7 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
6.2 | 36.9 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
6.1 | 12.3 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
6.1 | 6.1 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
6.1 | 30.6 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
6.1 | 6.1 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
6.1 | 97.7 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
6.1 | 73.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
6.0 | 60.3 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
6.0 | 18.1 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
6.0 | 18.0 | GO:1903445 | protein transport from ciliary membrane to plasma membrane(GO:1903445) |
6.0 | 36.0 | GO:0002517 | T cell tolerance induction(GO:0002517) |
6.0 | 17.9 | GO:0061744 | motor behavior(GO:0061744) |
5.9 | 41.4 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
5.9 | 47.3 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
5.9 | 11.8 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
5.9 | 123.7 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
5.9 | 29.4 | GO:0050755 | chemokine metabolic process(GO:0050755) |
5.9 | 17.6 | GO:1904401 | cellular response to Thyroid stimulating hormone(GO:1904401) |
5.8 | 17.4 | GO:1904373 | response to kainic acid(GO:1904373) |
5.8 | 5.8 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
5.8 | 46.4 | GO:0001842 | neural fold formation(GO:0001842) |
5.8 | 40.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
5.7 | 40.0 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
5.7 | 11.3 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
5.7 | 11.3 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
5.7 | 79.2 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
5.6 | 185.1 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
5.6 | 16.8 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
5.6 | 28.0 | GO:0015074 | DNA integration(GO:0015074) |
5.6 | 5.6 | GO:0007260 | tyrosine phosphorylation of STAT protein(GO:0007260) |
5.6 | 11.2 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
5.6 | 16.7 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
5.6 | 22.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
5.6 | 44.5 | GO:0016266 | O-glycan processing(GO:0016266) |
5.5 | 244.2 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
5.5 | 11.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
5.5 | 11.0 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
5.5 | 27.4 | GO:1904117 | cellular response to vasopressin(GO:1904117) |
5.5 | 163.7 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
5.4 | 16.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
5.4 | 10.9 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
5.4 | 21.7 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
5.4 | 10.8 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
5.4 | 10.8 | GO:0070084 | protein initiator methionine removal(GO:0070084) |
5.4 | 32.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
5.4 | 16.2 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
5.4 | 32.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
5.4 | 37.6 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
5.4 | 208.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
5.3 | 42.7 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
5.3 | 16.0 | GO:0010070 | zygote asymmetric cell division(GO:0010070) |
5.3 | 10.6 | GO:2000424 | regulation of eosinophil chemotaxis(GO:2000422) positive regulation of eosinophil chemotaxis(GO:2000424) |
5.3 | 242.7 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
5.3 | 10.5 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
5.3 | 10.5 | GO:1904528 | positive regulation of microtubule binding(GO:1904528) |
5.3 | 47.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
5.3 | 26.3 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
5.2 | 5.2 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
5.2 | 26.2 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
5.2 | 26.1 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
5.2 | 67.9 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
5.2 | 5.2 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
5.2 | 52.2 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
5.2 | 15.6 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
5.2 | 20.7 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
5.2 | 57.0 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
5.2 | 31.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
5.2 | 15.5 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
5.2 | 5.2 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
5.2 | 62.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
5.2 | 36.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
5.1 | 10.3 | GO:0002215 | defense response to nematode(GO:0002215) |
5.1 | 10.3 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
5.1 | 30.7 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
5.0 | 25.2 | GO:0030220 | platelet formation(GO:0030220) |
5.0 | 35.3 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
5.0 | 135.9 | GO:0019731 | antibacterial humoral response(GO:0019731) |
5.0 | 20.1 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
5.0 | 25.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
5.0 | 35.1 | GO:0006868 | glutamine transport(GO:0006868) |
5.0 | 20.0 | GO:0034759 | regulation of iron ion transmembrane transport(GO:0034759) negative regulation of iron ion transmembrane transport(GO:0034760) elastin biosynthetic process(GO:0051542) |
5.0 | 84.9 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
5.0 | 59.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
5.0 | 29.9 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
5.0 | 99.4 | GO:0006298 | mismatch repair(GO:0006298) |
4.9 | 24.7 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
4.9 | 4.9 | GO:0070370 | cellular heat acclimation(GO:0070370) |
4.9 | 49.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
4.9 | 19.7 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
4.9 | 34.4 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
4.9 | 14.7 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
4.9 | 166.8 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
4.9 | 24.5 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
4.9 | 53.9 | GO:0051310 | metaphase plate congression(GO:0051310) |
4.8 | 4.8 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
4.8 | 4.8 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
4.8 | 14.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
4.8 | 19.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
4.8 | 14.3 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
4.8 | 33.3 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
4.8 | 23.8 | GO:0035912 | dorsal aorta morphogenesis(GO:0035912) |
4.7 | 18.9 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
4.7 | 37.8 | GO:0007021 | tubulin complex assembly(GO:0007021) |
4.7 | 61.2 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
4.7 | 4.7 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
4.7 | 32.9 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
4.7 | 18.8 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
4.7 | 23.4 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
4.7 | 42.1 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
4.6 | 88.2 | GO:0006491 | N-glycan processing(GO:0006491) |
4.6 | 111.3 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
4.6 | 13.9 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
4.6 | 124.9 | GO:0007099 | centriole replication(GO:0007099) |
4.6 | 13.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
4.6 | 9.2 | GO:0035600 | tRNA methylthiolation(GO:0035600) |
4.6 | 13.7 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
4.6 | 36.5 | GO:0097068 | response to thyroxine(GO:0097068) |
4.6 | 4.6 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
4.6 | 18.2 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
4.6 | 4.6 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
4.5 | 13.6 | GO:0009249 | protein lipoylation(GO:0009249) |
4.5 | 17.9 | GO:0010266 | response to vitamin B1(GO:0010266) |
4.5 | 4.5 | GO:0034769 | basement membrane disassembly(GO:0034769) |
4.5 | 13.4 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
4.4 | 35.6 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
4.4 | 13.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
4.4 | 185.9 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
4.4 | 8.8 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
4.4 | 13.2 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
4.4 | 17.6 | GO:0044211 | CTP salvage(GO:0044211) |
4.4 | 8.8 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
4.4 | 17.6 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
4.4 | 39.5 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
4.3 | 17.4 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
4.3 | 26.1 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
4.3 | 73.3 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
4.3 | 12.8 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
4.2 | 42.5 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
4.2 | 4.2 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
4.2 | 12.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
4.2 | 12.7 | GO:0018992 | germ-line sex determination(GO:0018992) |
4.2 | 12.6 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
4.2 | 21.0 | GO:0022614 | membrane to membrane docking(GO:0022614) |
4.2 | 29.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
4.2 | 8.4 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
4.2 | 46.0 | GO:0045023 | G0 to G1 transition(GO:0045023) |
4.2 | 20.9 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
4.2 | 12.5 | GO:0097298 | regulation of nucleus size(GO:0097298) |
4.1 | 12.4 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
4.1 | 8.3 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
4.1 | 16.4 | GO:0031179 | peptide modification(GO:0031179) |
4.1 | 12.3 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
4.1 | 4.1 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
4.1 | 8.2 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
4.1 | 28.5 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
4.1 | 4.1 | GO:0089709 | histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
4.1 | 4.1 | GO:0048298 | regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
4.0 | 28.1 | GO:0043476 | endosome to melanosome transport(GO:0035646) pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
4.0 | 8.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
4.0 | 16.0 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
4.0 | 16.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
4.0 | 123.6 | GO:0002181 | cytoplasmic translation(GO:0002181) |
4.0 | 51.8 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
4.0 | 4.0 | GO:0071245 | cellular response to carbon monoxide(GO:0071245) |
3.9 | 7.9 | GO:0071503 | response to heparin(GO:0071503) |
3.9 | 11.8 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
3.9 | 35.1 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
3.9 | 19.4 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
3.9 | 7.8 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
3.9 | 3.9 | GO:0061724 | lipophagy(GO:0061724) |
3.8 | 30.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
3.8 | 7.6 | GO:0007356 | thorax and anterior abdomen determination(GO:0007356) |
3.8 | 11.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
3.8 | 11.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
3.8 | 15.1 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
3.8 | 7.6 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
3.8 | 22.7 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
3.8 | 3.8 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
3.8 | 26.4 | GO:0043686 | co-translational protein modification(GO:0043686) |
3.7 | 3.7 | GO:1904400 | response to Thyroid stimulating hormone(GO:1904400) |
3.7 | 14.8 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
3.7 | 18.4 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
3.7 | 18.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
3.7 | 11.0 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
3.7 | 18.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
3.6 | 7.2 | GO:0097037 | heme export(GO:0097037) |
3.6 | 7.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
3.6 | 3.6 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
3.6 | 10.8 | GO:1903165 | response to polycyclic arene(GO:1903165) |
3.6 | 42.9 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
3.6 | 7.2 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
3.6 | 17.8 | GO:0000733 | DNA strand renaturation(GO:0000733) |
3.6 | 298.5 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
3.5 | 7.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
3.5 | 10.6 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
3.5 | 42.2 | GO:0032365 | intracellular lipid transport(GO:0032365) |
3.5 | 84.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
3.5 | 21.0 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
3.5 | 10.5 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
3.5 | 17.5 | GO:0051299 | centrosome separation(GO:0051299) |
3.5 | 17.4 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
3.5 | 139.0 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
3.5 | 27.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
3.5 | 6.9 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
3.5 | 24.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
3.4 | 34.5 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
3.4 | 24.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
3.4 | 10.3 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
3.4 | 34.3 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
3.4 | 3.4 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
3.4 | 17.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
3.4 | 47.8 | GO:1902041 | regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902041) |
3.4 | 20.3 | GO:0002507 | tolerance induction(GO:0002507) |
3.4 | 10.1 | GO:0072144 | glomerular mesangial cell development(GO:0072144) |
3.4 | 6.8 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
3.4 | 10.1 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
3.4 | 13.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
3.4 | 10.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
3.4 | 20.2 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
3.3 | 23.4 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
3.3 | 43.3 | GO:0031268 | pseudopodium organization(GO:0031268) |
3.3 | 13.3 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
3.3 | 19.8 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
3.3 | 9.9 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
3.3 | 13.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
3.3 | 6.5 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
3.3 | 13.1 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
3.3 | 6.5 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
3.3 | 9.8 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
3.3 | 42.4 | GO:0016180 | snRNA processing(GO:0016180) |
3.3 | 26.0 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
3.2 | 6.5 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
3.2 | 3.2 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
3.2 | 6.4 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
3.2 | 16.1 | GO:1904044 | response to aldosterone(GO:1904044) |
3.2 | 16.1 | GO:0006968 | cellular defense response(GO:0006968) |
3.2 | 9.6 | GO:0021508 | floor plate formation(GO:0021508) floor plate morphogenesis(GO:0033505) |
3.2 | 57.7 | GO:0051028 | mRNA transport(GO:0051028) |
3.2 | 3.2 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
3.2 | 15.9 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
3.2 | 22.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
3.2 | 28.6 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
3.2 | 82.5 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
3.2 | 41.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
3.1 | 28.3 | GO:0050832 | defense response to fungus(GO:0050832) |
3.1 | 9.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
3.1 | 6.3 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
3.1 | 15.6 | GO:1901656 | glycoside transport(GO:1901656) |
3.1 | 24.9 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
3.1 | 12.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
3.1 | 9.2 | GO:0021571 | rhombomere 3 development(GO:0021569) rhombomere 5 development(GO:0021571) |
3.1 | 55.3 | GO:0038092 | nodal signaling pathway(GO:0038092) |
3.1 | 9.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
3.1 | 18.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
3.0 | 3.0 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
3.0 | 36.6 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
3.0 | 9.1 | GO:2000327 | positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
3.0 | 15.2 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
3.0 | 63.6 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
3.0 | 18.1 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
3.0 | 45.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
3.0 | 48.1 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
3.0 | 122.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
3.0 | 104.8 | GO:0031047 | gene silencing by RNA(GO:0031047) |
3.0 | 9.0 | GO:0060764 | cell-cell signaling involved in mammary gland development(GO:0060764) |
3.0 | 9.0 | GO:0030576 | Cajal body organization(GO:0030576) |
3.0 | 8.9 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
3.0 | 17.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
3.0 | 5.9 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
3.0 | 32.7 | GO:0033260 | nuclear DNA replication(GO:0033260) |
3.0 | 3.0 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
3.0 | 5.9 | GO:0032494 | response to peptidoglycan(GO:0032494) |
3.0 | 11.8 | GO:0006312 | mitotic recombination(GO:0006312) |
3.0 | 3.0 | GO:1903544 | response to butyrate(GO:1903544) |
2.9 | 26.5 | GO:0060056 | mammary gland involution(GO:0060056) |
2.9 | 2.9 | GO:0010934 | macrophage cytokine production(GO:0010934) regulation of macrophage cytokine production(GO:0010935) |
2.9 | 17.5 | GO:0051014 | actin filament severing(GO:0051014) |
2.9 | 2.9 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
2.9 | 35.0 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
2.9 | 5.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
2.9 | 98.6 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
2.9 | 5.8 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
2.9 | 17.3 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
2.9 | 11.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
2.9 | 2.9 | GO:0098707 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
2.9 | 8.6 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
2.9 | 17.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
2.9 | 8.6 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
2.9 | 17.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
2.9 | 57.1 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
2.8 | 37.0 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
2.8 | 5.7 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
2.8 | 8.5 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
2.8 | 8.4 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
2.8 | 33.6 | GO:0050872 | white fat cell differentiation(GO:0050872) |
2.8 | 2.8 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
2.8 | 8.3 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
2.7 | 5.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
2.7 | 16.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
2.7 | 5.4 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
2.7 | 46.0 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
2.7 | 21.5 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
2.7 | 16.0 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
2.7 | 354.5 | GO:0008380 | RNA splicing(GO:0008380) |
2.6 | 15.9 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
2.6 | 18.4 | GO:0006477 | protein sulfation(GO:0006477) |
2.6 | 10.5 | GO:0016115 | isoprenoid catabolic process(GO:0008300) diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
2.6 | 115.2 | GO:0043966 | histone H3 acetylation(GO:0043966) |
2.6 | 10.4 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
2.6 | 5.2 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
2.6 | 20.8 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
2.6 | 5.2 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
2.6 | 25.9 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
2.6 | 10.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
2.6 | 2.6 | GO:0048241 | epinephrine transport(GO:0048241) |
2.6 | 5.2 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
2.6 | 12.8 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
2.6 | 7.7 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) positive regulation of endoplasmic reticulum tubular network organization(GO:1903373) |
2.6 | 7.7 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
2.6 | 15.4 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
2.5 | 7.6 | GO:0007398 | ectoderm development(GO:0007398) |
2.5 | 10.1 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) positive regulation of retinal ganglion cell axon guidance(GO:1902336) |
2.5 | 5.0 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
2.5 | 5.0 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
2.5 | 5.0 | GO:0003342 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
2.5 | 2.5 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
2.5 | 5.0 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
2.5 | 7.4 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
2.5 | 32.1 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
2.5 | 7.4 | GO:0046333 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
2.4 | 19.6 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
2.4 | 14.7 | GO:0090179 | regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) planar cell polarity pathway involved in neural tube closure(GO:0090179) |
2.4 | 4.9 | GO:0070227 | lymphocyte apoptotic process(GO:0070227) |
2.4 | 14.5 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
2.4 | 7.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
2.4 | 19.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
2.4 | 23.9 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
2.4 | 9.6 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
2.4 | 33.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
2.4 | 16.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
2.4 | 7.2 | GO:0048102 | autophagic cell death(GO:0048102) |
2.4 | 33.3 | GO:0046415 | urate metabolic process(GO:0046415) |
2.4 | 2.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
2.4 | 7.1 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
2.4 | 7.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
2.4 | 2.4 | GO:0097286 | iron ion import(GO:0097286) |
2.4 | 75.2 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
2.4 | 7.1 | GO:0061450 | trophoblast cell migration(GO:0061450) |
2.3 | 9.4 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
2.3 | 9.4 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
2.3 | 7.0 | GO:0046380 | N-acetylglucosamine biosynthetic process(GO:0006045) N-acetylneuraminate biosynthetic process(GO:0046380) glucosamine-containing compound biosynthetic process(GO:1901073) |
2.3 | 4.6 | GO:0016240 | autophagosome docking(GO:0016240) |
2.3 | 4.6 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
2.3 | 9.3 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
2.3 | 23.2 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
2.3 | 48.6 | GO:0019835 | cytolysis(GO:0019835) |
2.3 | 23.0 | GO:0015671 | oxygen transport(GO:0015671) |
2.3 | 2.3 | GO:0031620 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
2.3 | 6.9 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
2.3 | 13.7 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
2.3 | 31.7 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
2.3 | 6.8 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
2.2 | 9.0 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
2.2 | 80.5 | GO:0051225 | spindle assembly(GO:0051225) |
2.2 | 13.4 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
2.2 | 8.8 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
2.2 | 4.4 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
2.2 | 6.6 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
2.2 | 13.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
2.2 | 19.8 | GO:1904353 | regulation of telomere capping(GO:1904353) positive regulation of telomere capping(GO:1904355) |
2.2 | 4.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
2.2 | 63.1 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
2.2 | 30.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
2.2 | 2.2 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
2.1 | 89.4 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
2.1 | 6.4 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
2.1 | 10.6 | GO:0038203 | TORC2 signaling(GO:0038203) |
2.1 | 4.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
2.1 | 19.1 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
2.1 | 4.2 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
2.1 | 12.7 | GO:0030852 | regulation of granulocyte differentiation(GO:0030852) |
2.1 | 6.3 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
2.1 | 31.6 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
2.1 | 18.9 | GO:0032506 | cytokinetic process(GO:0032506) |
2.1 | 8.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
2.1 | 25.2 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
2.1 | 46.1 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
2.1 | 8.4 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
2.1 | 14.6 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
2.1 | 12.5 | GO:0019985 | translesion synthesis(GO:0019985) |
2.1 | 43.6 | GO:0002819 | regulation of adaptive immune response(GO:0002819) |
2.1 | 195.2 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
2.1 | 2.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
2.1 | 4.2 | GO:0048539 | bone marrow development(GO:0048539) |
2.1 | 4.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
2.1 | 4.1 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
2.1 | 61.8 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) |
2.1 | 10.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
2.0 | 8.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
2.0 | 16.4 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
2.0 | 2.0 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
2.0 | 28.5 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
2.0 | 14.3 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
2.0 | 8.1 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
2.0 | 73.1 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
2.0 | 28.4 | GO:0001675 | acrosome assembly(GO:0001675) |
2.0 | 2.0 | GO:0015966 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
2.0 | 10.1 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
2.0 | 6.1 | GO:1901423 | response to benzene(GO:1901423) |
2.0 | 8.0 | GO:1901031 | regulation of response to reactive oxygen species(GO:1901031) |
2.0 | 14.0 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
2.0 | 6.0 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
2.0 | 29.8 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
2.0 | 6.0 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
2.0 | 4.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
2.0 | 17.6 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
2.0 | 11.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
2.0 | 31.3 | GO:1903205 | regulation of hydrogen peroxide-induced cell death(GO:1903205) |
1.9 | 7.8 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
1.9 | 27.2 | GO:0072698 | protein localization to microtubule cytoskeleton(GO:0072698) |
1.9 | 5.8 | GO:0009838 | abscission(GO:0009838) |
1.9 | 7.8 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
1.9 | 9.7 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
1.9 | 9.7 | GO:0001582 | detection of chemical stimulus involved in sensory perception of sweet taste(GO:0001582) |
1.9 | 7.7 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
1.9 | 9.6 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
1.9 | 1.9 | GO:0090166 | Golgi disassembly(GO:0090166) |
1.9 | 13.4 | GO:0055070 | copper ion homeostasis(GO:0055070) |
1.9 | 13.3 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
1.9 | 9.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
1.9 | 15.0 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
1.9 | 24.3 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
1.9 | 7.5 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
1.9 | 7.5 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
1.8 | 3.7 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
1.8 | 3.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
1.8 | 3.7 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.8 | 12.9 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.8 | 7.4 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
1.8 | 34.7 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
1.8 | 5.5 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
1.8 | 1.8 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
1.8 | 3.6 | GO:0048341 | paraxial mesoderm morphogenesis(GO:0048340) paraxial mesoderm formation(GO:0048341) |
1.8 | 3.6 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
1.8 | 7.2 | GO:0060005 | vestibular reflex(GO:0060005) |
1.8 | 8.9 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.8 | 42.9 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
1.8 | 7.1 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
1.8 | 7.1 | GO:0046512 | sphingosine biosynthetic process(GO:0046512) |
1.8 | 12.4 | GO:0036065 | fucosylation(GO:0036065) |
1.8 | 5.3 | GO:0002327 | immature B cell differentiation(GO:0002327) |
1.8 | 7.1 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
1.8 | 5.3 | GO:0032218 | riboflavin transport(GO:0032218) |
1.8 | 17.6 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
1.8 | 149.0 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
1.7 | 15.7 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
1.7 | 3.5 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
1.7 | 3.5 | GO:0016441 | posttranscriptional gene silencing(GO:0016441) |
1.7 | 3.5 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
1.7 | 5.2 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
1.7 | 15.4 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
1.7 | 5.1 | GO:0060613 | fat pad development(GO:0060613) |
1.7 | 10.2 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
1.7 | 5.1 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.7 | 28.7 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
1.7 | 15.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
1.7 | 5.0 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
1.7 | 3.4 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
1.7 | 5.0 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
1.7 | 18.4 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
1.7 | 3.3 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
1.6 | 37.9 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
1.6 | 3.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.6 | 21.2 | GO:0006284 | base-excision repair(GO:0006284) |
1.6 | 3.3 | GO:0022616 | DNA strand elongation(GO:0022616) |
1.6 | 11.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
1.6 | 51.7 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
1.6 | 14.5 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
1.6 | 11.3 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
1.6 | 6.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
1.6 | 4.8 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
1.6 | 12.7 | GO:0007052 | mitotic spindle organization(GO:0007052) |
1.6 | 3.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
1.6 | 9.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
1.5 | 26.2 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
1.5 | 1.5 | GO:1902590 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
1.5 | 10.6 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
1.5 | 6.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.5 | 3.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
1.5 | 6.0 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.5 | 19.5 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
1.5 | 16.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
1.5 | 7.4 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
1.5 | 3.0 | GO:0043129 | surfactant homeostasis(GO:0043129) |
1.5 | 51.8 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
1.5 | 8.9 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
1.5 | 42.7 | GO:0070207 | protein homotrimerization(GO:0070207) |
1.5 | 16.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
1.5 | 2.9 | GO:0000012 | single strand break repair(GO:0000012) |
1.5 | 5.8 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
1.4 | 4.3 | GO:0090399 | replicative senescence(GO:0090399) |
1.4 | 4.3 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
1.4 | 15.6 | GO:0007567 | parturition(GO:0007567) |
1.4 | 11.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.4 | 8.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
1.4 | 8.4 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
1.4 | 4.2 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
1.4 | 4.2 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
1.4 | 16.8 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
1.4 | 5.6 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
1.4 | 1.4 | GO:0030167 | proteoglycan catabolic process(GO:0030167) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
1.4 | 8.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
1.4 | 13.9 | GO:0097205 | renal filtration(GO:0097205) |
1.4 | 5.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.4 | 9.6 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
1.4 | 16.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
1.4 | 12.2 | GO:0030168 | platelet activation(GO:0030168) |
1.3 | 12.1 | GO:0071280 | cellular response to copper ion(GO:0071280) |
1.3 | 20.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
1.3 | 18.6 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
1.3 | 5.3 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
1.3 | 2.6 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
1.3 | 13.0 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
1.3 | 3.9 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
1.3 | 2.6 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
1.3 | 40.1 | GO:0071897 | DNA biosynthetic process(GO:0071897) |
1.3 | 2.6 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
1.3 | 42.3 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
1.3 | 24.2 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
1.3 | 97.2 | GO:0090630 | activation of GTPase activity(GO:0090630) |
1.3 | 3.8 | GO:0034969 | histone arginine methylation(GO:0034969) |
1.3 | 11.3 | GO:0007603 | phototransduction, visible light(GO:0007603) |
1.3 | 7.6 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.3 | 54.1 | GO:0006397 | mRNA processing(GO:0006397) |
1.2 | 5.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
1.2 | 24.9 | GO:0097421 | liver regeneration(GO:0097421) |
1.2 | 3.7 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
1.2 | 46.9 | GO:0006413 | translational initiation(GO:0006413) |
1.2 | 37.0 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
1.2 | 22.2 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
1.2 | 7.4 | GO:0007143 | female meiotic division(GO:0007143) |
1.2 | 12.3 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
1.2 | 17.1 | GO:0032608 | interferon-beta production(GO:0032608) |
1.2 | 3.7 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
1.2 | 9.8 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.2 | 7.3 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
1.2 | 3.6 | GO:0070307 | lens fiber cell development(GO:0070307) |
1.2 | 2.4 | GO:0070638 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
1.2 | 1.2 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
1.2 | 11.8 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
1.2 | 2.4 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
1.2 | 3.5 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
1.2 | 7.1 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
1.2 | 7.0 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
1.2 | 5.8 | GO:0060770 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
1.2 | 4.7 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
1.2 | 3.5 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
1.2 | 2.3 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
1.2 | 8.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
1.2 | 3.5 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.2 | 3.5 | GO:0042891 | antibiotic transport(GO:0042891) |
1.1 | 1.1 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
1.1 | 10.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
1.1 | 6.8 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
1.1 | 3.4 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
1.1 | 6.7 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.1 | 5.6 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
1.1 | 2.2 | GO:0050828 | regulation of liquid surface tension(GO:0050828) |
1.1 | 4.4 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
1.1 | 7.7 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
1.1 | 16.3 | GO:0007602 | phototransduction(GO:0007602) |
1.1 | 6.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
1.1 | 3.3 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
1.1 | 23.8 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
1.1 | 5.4 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) |
1.1 | 2.2 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
1.1 | 5.4 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
1.1 | 7.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.1 | 3.2 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
1.1 | 6.3 | GO:0045582 | positive regulation of T cell differentiation(GO:0045582) |
1.1 | 2.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
1.1 | 4.2 | GO:0072520 | seminiferous tubule development(GO:0072520) |
1.0 | 7.3 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
1.0 | 6.2 | GO:0048820 | hair follicle maturation(GO:0048820) |
1.0 | 5.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.0 | 2.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.0 | 3.1 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
1.0 | 5.2 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
1.0 | 318.7 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
1.0 | 5.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.0 | 16.4 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
1.0 | 9.2 | GO:0070206 | protein trimerization(GO:0070206) |
1.0 | 20.3 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
1.0 | 17.2 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
1.0 | 4.0 | GO:0008355 | olfactory learning(GO:0008355) |
1.0 | 10.1 | GO:0032329 | serine transport(GO:0032329) |
1.0 | 4.0 | GO:0002934 | desmosome organization(GO:0002934) |
1.0 | 6.9 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
1.0 | 5.0 | GO:0060430 | lung saccule development(GO:0060430) |
1.0 | 3.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
1.0 | 17.6 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
1.0 | 4.9 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
1.0 | 2.9 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.9 | 1.9 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.9 | 19.6 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.9 | 0.9 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
0.9 | 1.9 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.9 | 5.6 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.9 | 1.8 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.9 | 4.6 | GO:0034214 | protein hexamerization(GO:0034214) |
0.9 | 1.8 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.9 | 4.5 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.9 | 5.4 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.9 | 1.8 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.9 | 16.0 | GO:0010039 | response to iron ion(GO:0010039) |
0.9 | 3.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.9 | 6.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.9 | 2.6 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.9 | 15.6 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.9 | 0.9 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.8 | 1.7 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.8 | 11.7 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.8 | 5.0 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.8 | 9.0 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.8 | 2.5 | GO:0001510 | RNA methylation(GO:0001510) |
0.8 | 3.3 | GO:1904717 | regulation of AMPA glutamate receptor clustering(GO:1904717) |
0.8 | 18.1 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.8 | 9.8 | GO:0045056 | transcytosis(GO:0045056) |
0.8 | 5.7 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.8 | 56.1 | GO:0019827 | stem cell population maintenance(GO:0019827) |
0.8 | 4.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.8 | 24.2 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.8 | 10.5 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.8 | 5.6 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.8 | 6.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.8 | 0.8 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.8 | 8.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.8 | 6.9 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.8 | 13.9 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.8 | 4.6 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.8 | 3.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.8 | 1.5 | GO:0051935 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
0.8 | 40.9 | GO:0006260 | DNA replication(GO:0006260) |
0.8 | 9.8 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.8 | 9.8 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.8 | 24.9 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.8 | 4.5 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.7 | 2.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.7 | 4.5 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.7 | 3.7 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.7 | 1.5 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
0.7 | 3.7 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.7 | 5.8 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.7 | 5.1 | GO:0035307 | positive regulation of protein dephosphorylation(GO:0035307) |
0.7 | 7.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.7 | 3.6 | GO:1902745 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
0.7 | 6.5 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.7 | 10.8 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.7 | 11.5 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.7 | 1.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.7 | 7.9 | GO:0006809 | nitric oxide biosynthetic process(GO:0006809) |
0.7 | 2.9 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.7 | 10.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.7 | 0.7 | GO:1904835 | vestibulocochlear nerve structural organization(GO:0021649) cerebral cortex tangential migration using cell-axon interactions(GO:0021824) substrate-dependent cerebral cortex tangential migration(GO:0021825) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) cranial ganglion development(GO:0061550) trigeminal ganglion development(GO:0061551) ganglion morphogenesis(GO:0061552) facioacoustic ganglion development(GO:1903375) dorsal root ganglion morphogenesis(GO:1904835) dorsal root ganglion development(GO:1990791) |
0.7 | 2.1 | GO:0051414 | response to cortisol(GO:0051414) |
0.7 | 0.7 | GO:1902415 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) |
0.7 | 2.8 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
0.7 | 0.7 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.7 | 4.1 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.7 | 27.5 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.6 | 1.3 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.6 | 1.3 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.6 | 4.4 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.6 | 10.7 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
0.6 | 2.5 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.6 | 3.1 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.6 | 1.8 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
0.6 | 3.7 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.6 | 4.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.6 | 6.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.6 | 6.0 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.6 | 3.0 | GO:0034389 | lipid particle organization(GO:0034389) |
0.6 | 1.8 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.6 | 7.1 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.6 | 2.9 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.6 | 2.3 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.6 | 6.8 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.6 | 0.6 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.6 | 6.7 | GO:0000075 | cell cycle checkpoint(GO:0000075) |
0.6 | 1.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.6 | 1.7 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.5 | 6.6 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.5 | 3.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.5 | 1.6 | GO:0015811 | L-cystine transport(GO:0015811) |
0.5 | 14.9 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.5 | 3.6 | GO:0006907 | pinocytosis(GO:0006907) |
0.5 | 1.6 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.5 | 3.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.5 | 1.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.5 | 2.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.5 | 7.2 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.5 | 3.1 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.5 | 5.5 | GO:0097320 | membrane tubulation(GO:0097320) |
0.5 | 2.5 | GO:1901142 | insulin processing(GO:0030070) insulin metabolic process(GO:1901142) |
0.5 | 2.0 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.5 | 2.9 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.5 | 1.9 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.5 | 1.9 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.5 | 3.7 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.5 | 5.5 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.4 | 6.7 | GO:0009112 | nucleobase metabolic process(GO:0009112) |
0.4 | 5.3 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.4 | 2.2 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.4 | 49.4 | GO:0006913 | nucleocytoplasmic transport(GO:0006913) |
0.4 | 2.5 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.4 | 0.4 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.4 | 0.8 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.4 | 4.5 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.4 | 4.5 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.4 | 1.6 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.4 | 0.4 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.4 | 2.8 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.4 | 1.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.4 | 3.8 | GO:0007140 | male meiosis(GO:0007140) |
0.4 | 0.7 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.4 | 0.4 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.3 | 3.5 | GO:2000648 | positive regulation of stem cell proliferation(GO:2000648) |
0.3 | 0.7 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.3 | 0.7 | GO:0042533 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.3 | 5.0 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.3 | 2.9 | GO:0045682 | regulation of epidermis development(GO:0045682) |
0.3 | 1.2 | GO:0003360 | brainstem development(GO:0003360) |
0.3 | 1.5 | GO:0001927 | exocyst assembly(GO:0001927) |
0.3 | 0.3 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.3 | 1.2 | GO:0032919 | spermine acetylation(GO:0032919) |
0.3 | 1.5 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.3 | 1.8 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.3 | 1.2 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.3 | 0.9 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.3 | 1.4 | GO:0015677 | copper ion import(GO:0015677) |
0.3 | 0.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.3 | 1.7 | GO:0097264 | self proteolysis(GO:0097264) |
0.3 | 0.3 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.3 | 0.8 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.3 | 1.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 1.0 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.2 | 1.5 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
0.2 | 1.7 | GO:0050000 | chromosome localization(GO:0050000) |
0.2 | 1.0 | GO:0048252 | lauric acid metabolic process(GO:0048252) |
0.2 | 6.4 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.2 | 0.9 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.2 | 0.5 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.2 | 13.3 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.2 | 3.4 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.2 | 1.2 | GO:0010165 | response to X-ray(GO:0010165) |
0.2 | 0.6 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.2 | 0.5 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.2 | 0.2 | GO:0061056 | sclerotome development(GO:0061056) |
0.2 | 0.2 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.2 | 0.8 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 7.3 | GO:0034470 | ncRNA processing(GO:0034470) |
0.2 | 0.6 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.2 | 1.4 | GO:0015695 | organic cation transport(GO:0015695) |
0.2 | 2.1 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.2 | 1.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.6 | GO:0051958 | methotrexate transport(GO:0051958) |
0.1 | 0.9 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.3 | GO:0009751 | response to salicylic acid(GO:0009751) |
0.1 | 2.9 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 1.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.9 | GO:0006833 | water transport(GO:0006833) |
0.1 | 1.4 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.7 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.1 | 1.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.9 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 1.2 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.1 | 0.6 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.1 | 0.1 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.1 | 0.3 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.1 | 0.1 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.0 | 0.0 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.2 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.2 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.0 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
49.1 | 392.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
42.1 | 42.1 | GO:0045298 | tubulin complex(GO:0045298) |
36.8 | 110.4 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
35.2 | 105.5 | GO:0044609 | DBIRD complex(GO:0044609) |
34.3 | 137.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
33.7 | 101.1 | GO:0035101 | FACT complex(GO:0035101) |
30.0 | 30.0 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
29.0 | 260.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
25.7 | 102.6 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
24.2 | 217.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
23.5 | 47.0 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
22.8 | 365.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
22.0 | 175.9 | GO:0044194 | cytolytic granule(GO:0044194) |
21.5 | 64.4 | GO:0000811 | GINS complex(GO:0000811) |
21.4 | 64.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
21.3 | 85.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
21.2 | 126.9 | GO:0032133 | chromosome passenger complex(GO:0032133) |
19.9 | 139.3 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
19.6 | 98.2 | GO:0034455 | t-UTP complex(GO:0034455) |
18.7 | 168.4 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
18.3 | 146.4 | GO:0000796 | condensin complex(GO:0000796) |
17.9 | 628.2 | GO:0001772 | immunological synapse(GO:0001772) |
16.9 | 50.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
16.7 | 200.7 | GO:0005687 | U4 snRNP(GO:0005687) |
16.1 | 48.4 | GO:0032173 | septin collar(GO:0032173) |
15.8 | 126.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
15.4 | 46.1 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
15.1 | 166.0 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
14.8 | 44.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
14.8 | 59.0 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
14.8 | 103.3 | GO:0001652 | granular component(GO:0001652) |
14.1 | 56.4 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
14.1 | 183.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
13.5 | 376.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
13.1 | 52.5 | GO:0018444 | translation release factor complex(GO:0018444) |
13.1 | 39.3 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
13.1 | 26.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
13.0 | 65.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
12.9 | 90.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
12.7 | 38.2 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
12.0 | 311.1 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
11.8 | 58.9 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
11.4 | 11.4 | GO:0001740 | Barr body(GO:0001740) |
11.4 | 137.0 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
11.4 | 34.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
11.1 | 66.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
10.9 | 87.0 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
10.5 | 10.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
10.5 | 21.0 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
10.4 | 52.2 | GO:0098536 | deuterosome(GO:0098536) |
10.1 | 50.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
10.0 | 40.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
10.0 | 89.9 | GO:0042555 | MCM complex(GO:0042555) |
10.0 | 59.9 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
9.8 | 29.5 | GO:0061574 | ASAP complex(GO:0061574) |
9.8 | 97.6 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
9.5 | 57.0 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
9.3 | 74.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
9.3 | 46.4 | GO:0097165 | nuclear stress granule(GO:0097165) |
9.2 | 36.8 | GO:0097149 | centralspindlin complex(GO:0097149) |
9.0 | 27.0 | GO:0060187 | cell pole(GO:0060187) |
8.8 | 61.8 | GO:0043203 | axon hillock(GO:0043203) |
8.8 | 43.8 | GO:0031085 | BLOC-3 complex(GO:0031085) |
8.7 | 34.9 | GO:0097427 | microtubule bundle(GO:0097427) |
8.6 | 154.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
8.5 | 111.1 | GO:0005686 | U2 snRNP(GO:0005686) |
8.5 | 93.7 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
8.4 | 59.0 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
8.4 | 33.7 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
8.3 | 624.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
8.2 | 81.8 | GO:0097433 | dense body(GO:0097433) |
8.2 | 40.8 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
8.1 | 56.9 | GO:0005688 | U6 snRNP(GO:0005688) |
8.0 | 24.0 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
7.8 | 31.2 | GO:0097342 | ripoptosome(GO:0097342) |
7.8 | 39.0 | GO:0097443 | sorting endosome(GO:0097443) |
7.8 | 23.3 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
7.8 | 15.5 | GO:0070578 | RISC-loading complex(GO:0070578) |
7.7 | 123.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
7.6 | 37.9 | GO:0043293 | apoptosome(GO:0043293) |
7.3 | 682.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
7.2 | 173.6 | GO:0032040 | small-subunit processome(GO:0032040) |
7.2 | 14.4 | GO:0016342 | catenin complex(GO:0016342) |
7.2 | 21.6 | GO:0071564 | npBAF complex(GO:0071564) |
7.2 | 71.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
7.2 | 42.9 | GO:0036396 | MIS complex(GO:0036396) |
7.2 | 21.5 | GO:0071438 | invadopodium membrane(GO:0071438) |
7.1 | 7.1 | GO:0055087 | Ski complex(GO:0055087) |
7.0 | 55.8 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
6.9 | 48.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
6.9 | 61.9 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
6.8 | 34.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
6.6 | 46.1 | GO:0042825 | TAP complex(GO:0042825) |
6.6 | 210.3 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
6.5 | 32.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
6.5 | 91.0 | GO:0031091 | platelet alpha granule(GO:0031091) |
6.5 | 90.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
6.4 | 51.5 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
6.4 | 102.8 | GO:0070938 | contractile ring(GO:0070938) |
6.4 | 38.5 | GO:0070847 | core mediator complex(GO:0070847) |
6.4 | 19.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
6.3 | 361.6 | GO:0005657 | replication fork(GO:0005657) |
6.3 | 405.9 | GO:0005871 | kinesin complex(GO:0005871) |
6.3 | 25.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
6.3 | 88.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
6.3 | 18.8 | GO:0097413 | Lewy body(GO:0097413) |
6.3 | 106.4 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
6.1 | 79.7 | GO:0072687 | meiotic spindle(GO:0072687) |
6.1 | 12.2 | GO:0070876 | SOSS complex(GO:0070876) |
6.1 | 79.2 | GO:0000801 | central element(GO:0000801) |
6.1 | 66.6 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
6.0 | 30.2 | GO:0000974 | Prp19 complex(GO:0000974) |
6.0 | 41.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
5.9 | 47.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
5.9 | 11.8 | GO:0000346 | transcription export complex(GO:0000346) |
5.9 | 23.4 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
5.8 | 439.3 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
5.5 | 60.7 | GO:0042588 | zymogen granule(GO:0042588) |
5.5 | 55.2 | GO:0070652 | HAUS complex(GO:0070652) |
5.5 | 16.5 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
5.5 | 16.4 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
5.4 | 48.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
5.4 | 53.5 | GO:0070187 | telosome(GO:0070187) |
5.3 | 138.4 | GO:0001891 | phagocytic cup(GO:0001891) |
5.3 | 53.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
5.3 | 31.8 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
5.3 | 10.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
5.3 | 47.4 | GO:0031209 | SCAR complex(GO:0031209) |
5.3 | 10.5 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
5.2 | 15.7 | GO:0070421 | DNA ligase III-XRCC1 complex(GO:0070421) |
5.2 | 161.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
5.2 | 20.8 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
5.2 | 62.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
5.1 | 10.3 | GO:0070449 | elongin complex(GO:0070449) |
5.1 | 45.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
5.1 | 1499.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
5.0 | 15.1 | GO:1902560 | GMP reductase complex(GO:1902560) |
5.0 | 25.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
5.0 | 20.0 | GO:0000938 | GARP complex(GO:0000938) |
5.0 | 148.7 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
4.9 | 4.9 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
4.8 | 29.0 | GO:0042382 | paraspeckles(GO:0042382) |
4.8 | 9.6 | GO:0032389 | MutLalpha complex(GO:0032389) |
4.8 | 33.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
4.7 | 18.8 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
4.7 | 4.7 | GO:0042827 | platelet dense granule membrane(GO:0031088) platelet dense granule(GO:0042827) |
4.6 | 4.6 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
4.6 | 23.2 | GO:0035061 | interchromatin granule(GO:0035061) |
4.5 | 18.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
4.5 | 67.2 | GO:0001741 | XY body(GO:0001741) |
4.5 | 4.5 | GO:0070552 | BRISC complex(GO:0070552) |
4.4 | 57.6 | GO:0032433 | filopodium tip(GO:0032433) |
4.4 | 8.8 | GO:1990423 | RZZ complex(GO:1990423) |
4.3 | 8.7 | GO:0070821 | tertiary granule membrane(GO:0070821) |
4.3 | 47.7 | GO:0031527 | filopodium membrane(GO:0031527) |
4.3 | 56.1 | GO:0030914 | STAGA complex(GO:0030914) |
4.3 | 8.6 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
4.3 | 17.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
4.3 | 17.0 | GO:0035339 | SPOTS complex(GO:0035339) |
4.2 | 16.9 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
4.2 | 16.9 | GO:0044299 | C-fiber(GO:0044299) |
4.2 | 21.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
4.2 | 25.3 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
4.1 | 53.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
4.1 | 24.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
4.1 | 8.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
4.1 | 20.3 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
4.1 | 28.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
4.0 | 44.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
4.0 | 52.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
4.0 | 12.0 | GO:0005745 | m-AAA complex(GO:0005745) |
4.0 | 36.0 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
4.0 | 27.8 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
4.0 | 47.6 | GO:0005876 | spindle microtubule(GO:0005876) |
3.9 | 39.4 | GO:0031143 | pseudopodium(GO:0031143) |
3.9 | 11.6 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
3.9 | 19.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
3.9 | 34.8 | GO:0032009 | early phagosome(GO:0032009) |
3.8 | 18.9 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
3.7 | 11.2 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
3.7 | 22.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
3.7 | 14.9 | GO:0071797 | LUBAC complex(GO:0071797) |
3.7 | 11.2 | GO:0097651 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
3.7 | 14.8 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
3.7 | 22.2 | GO:1990246 | uniplex complex(GO:1990246) |
3.7 | 44.3 | GO:0042581 | specific granule(GO:0042581) |
3.7 | 187.7 | GO:0000776 | kinetochore(GO:0000776) |
3.7 | 99.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
3.7 | 25.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
3.6 | 32.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
3.6 | 21.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
3.6 | 43.0 | GO:0044666 | MLL3/4 complex(GO:0044666) |
3.5 | 3.5 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
3.5 | 1049.4 | GO:0000790 | nuclear chromatin(GO:0000790) |
3.5 | 408.5 | GO:0001650 | fibrillar center(GO:0001650) |
3.4 | 24.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
3.4 | 10.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
3.4 | 44.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
3.4 | 17.0 | GO:0071547 | piP-body(GO:0071547) |
3.4 | 40.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
3.3 | 29.7 | GO:0008278 | cohesin complex(GO:0008278) |
3.3 | 6.6 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
3.3 | 19.7 | GO:0005879 | axonemal microtubule(GO:0005879) |
3.3 | 65.8 | GO:0002102 | podosome(GO:0002102) |
3.2 | 22.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
3.2 | 6.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
3.2 | 102.3 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
3.2 | 3.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
3.2 | 12.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
3.2 | 38.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
3.2 | 31.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
3.1 | 18.6 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
3.1 | 49.4 | GO:0032039 | integrator complex(GO:0032039) |
3.1 | 116.9 | GO:0000786 | nucleosome(GO:0000786) |
3.0 | 90.4 | GO:0034451 | centriolar satellite(GO:0034451) |
3.0 | 9.0 | GO:0035838 | growing cell tip(GO:0035838) |
3.0 | 14.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
2.9 | 38.1 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
2.9 | 8.7 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
2.9 | 17.4 | GO:0071203 | WASH complex(GO:0071203) |
2.9 | 46.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
2.9 | 26.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
2.9 | 71.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
2.8 | 111.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
2.8 | 16.6 | GO:0005638 | lamin filament(GO:0005638) |
2.8 | 11.1 | GO:0005607 | laminin-2 complex(GO:0005607) |
2.8 | 52.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
2.8 | 8.3 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
2.7 | 164.8 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
2.7 | 13.7 | GO:1990357 | terminal web(GO:1990357) |
2.7 | 5.5 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
2.7 | 16.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
2.7 | 37.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
2.7 | 13.3 | GO:0090543 | Flemming body(GO:0090543) |
2.6 | 10.6 | GO:0031417 | NatC complex(GO:0031417) |
2.6 | 45.0 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
2.6 | 23.7 | GO:0016600 | flotillin complex(GO:0016600) |
2.6 | 124.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
2.6 | 28.4 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
2.6 | 658.4 | GO:0016607 | nuclear speck(GO:0016607) |
2.4 | 4.8 | GO:0033503 | HULC complex(GO:0033503) |
2.4 | 16.8 | GO:0071986 | Ragulator complex(GO:0071986) |
2.4 | 35.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
2.4 | 287.3 | GO:0001726 | ruffle(GO:0001726) |
2.3 | 46.9 | GO:0015030 | Cajal body(GO:0015030) |
2.3 | 37.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
2.3 | 9.2 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
2.3 | 6.9 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
2.2 | 24.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
2.2 | 19.6 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
2.1 | 16.7 | GO:0019013 | viral nucleocapsid(GO:0019013) |
2.1 | 16.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
2.1 | 193.1 | GO:0005884 | actin filament(GO:0005884) |
2.1 | 4.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
2.1 | 4.1 | GO:0099522 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
2.1 | 6.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
2.0 | 59.3 | GO:0016235 | aggresome(GO:0016235) |
1.9 | 9.7 | GO:1903767 | sweet taste receptor complex(GO:1903767) taste receptor complex(GO:1903768) |
1.9 | 26.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
1.9 | 3.8 | GO:1990630 | IRE1-RACK1-PP2A complex(GO:1990630) |
1.9 | 136.0 | GO:0005814 | centriole(GO:0005814) |
1.9 | 507.8 | GO:0005925 | focal adhesion(GO:0005925) |
1.9 | 9.3 | GO:0031904 | endosome lumen(GO:0031904) |
1.8 | 90.2 | GO:0016605 | PML body(GO:0016605) |
1.8 | 35.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.7 | 43.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
1.7 | 301.1 | GO:0005694 | chromosome(GO:0005694) |
1.7 | 8.6 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
1.7 | 5.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.7 | 3.4 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
1.7 | 3.4 | GO:1990429 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
1.7 | 6.8 | GO:0032021 | NELF complex(GO:0032021) |
1.7 | 18.5 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
1.7 | 6.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.7 | 3.3 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
1.6 | 24.7 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
1.6 | 56.8 | GO:0016592 | mediator complex(GO:0016592) |
1.6 | 6.4 | GO:0097422 | tubular endosome(GO:0097422) |
1.6 | 6.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
1.6 | 3.2 | GO:0071942 | XPC complex(GO:0071942) |
1.6 | 4.7 | GO:0070826 | paraferritin complex(GO:0070826) |
1.5 | 4.5 | GO:0072487 | MSL complex(GO:0072487) |
1.5 | 6.0 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
1.5 | 4.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.5 | 34.1 | GO:0005681 | spliceosomal complex(GO:0005681) |
1.5 | 8.8 | GO:0090544 | BAF-type complex(GO:0090544) |
1.5 | 4.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.4 | 7.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.4 | 5.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.4 | 4.2 | GO:0043511 | inhibin complex(GO:0043511) |
1.4 | 7.0 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
1.4 | 5.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
1.4 | 12.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.4 | 24.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
1.4 | 9.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.3 | 10.7 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
1.3 | 14.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
1.3 | 6.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.3 | 6.7 | GO:0000439 | core TFIIH complex(GO:0000439) |
1.3 | 92.5 | GO:0045095 | keratin filament(GO:0045095) |
1.3 | 22.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.3 | 15.1 | GO:0030057 | desmosome(GO:0030057) |
1.3 | 16.3 | GO:0031519 | PcG protein complex(GO:0031519) |
1.2 | 9.9 | GO:0097542 | ciliary tip(GO:0097542) |
1.2 | 12.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
1.2 | 22.6 | GO:0032993 | protein-DNA complex(GO:0032993) |
1.2 | 18.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
1.2 | 11.5 | GO:0031082 | BLOC complex(GO:0031082) |
1.1 | 137.5 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
1.1 | 15.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
1.1 | 205.9 | GO:0005667 | transcription factor complex(GO:0005667) |
1.1 | 62.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
1.1 | 15.9 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
1.1 | 15.9 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
1.1 | 8.5 | GO:0044754 | autolysosome(GO:0044754) |
1.0 | 51.1 | GO:0000922 | spindle pole(GO:0000922) |
1.0 | 60.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
1.0 | 8.1 | GO:0030686 | 90S preribosome(GO:0030686) |
1.0 | 7.0 | GO:0031932 | TORC2 complex(GO:0031932) |
1.0 | 69.4 | GO:0030139 | endocytic vesicle(GO:0030139) |
1.0 | 51.0 | GO:0030027 | lamellipodium(GO:0030027) |
1.0 | 13.5 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
1.0 | 10.6 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
1.0 | 22.0 | GO:0005844 | polysome(GO:0005844) |
0.9 | 50.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.9 | 384.5 | GO:0005730 | nucleolus(GO:0005730) |
0.9 | 0.9 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.9 | 3.5 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.9 | 5.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.8 | 0.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.8 | 24.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.8 | 1.6 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.8 | 2.4 | GO:0034657 | GID complex(GO:0034657) |
0.8 | 2.3 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.7 | 9.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.7 | 22.5 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.7 | 12.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.7 | 0.7 | GO:0033290 | eukaryotic 48S preinitiation complex(GO:0033290) |
0.7 | 3.5 | GO:1990635 | proximal dendrite(GO:1990635) |
0.7 | 0.7 | GO:0032437 | cuticular plate(GO:0032437) |
0.7 | 3.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.6 | 15.5 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.6 | 3.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.6 | 45.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.6 | 3.0 | GO:0000242 | pericentriolar material(GO:0000242) |
0.6 | 656.2 | GO:0005654 | nucleoplasm(GO:0005654) |
0.6 | 12.7 | GO:0034399 | nuclear periphery(GO:0034399) |
0.6 | 5.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.5 | 19.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.5 | 14.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.4 | 3.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.4 | 1.1 | GO:0098833 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
0.4 | 0.4 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.3 | 14.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.3 | 0.3 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.3 | 6.0 | GO:0001533 | cornified envelope(GO:0001533) |
0.3 | 0.8 | GO:0048500 | signal recognition particle(GO:0048500) |
0.3 | 0.5 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 2.9 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 0.8 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 1.6 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.2 | 1.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 107.3 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.1 | GO:0043219 | lateral loop(GO:0043219) |
0.0 | 0.1 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
35.7 | 214.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
27.4 | 246.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
26.8 | 268.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
25.7 | 154.2 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
25.5 | 127.3 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
24.7 | 74.1 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
24.6 | 73.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
24.6 | 122.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
24.3 | 97.3 | GO:0035877 | death effector domain binding(GO:0035877) |
21.9 | 65.7 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
19.4 | 77.5 | GO:0042610 | CD8 receptor binding(GO:0042610) |
19.0 | 56.9 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
18.8 | 56.5 | GO:0008481 | sphinganine kinase activity(GO:0008481) |
18.6 | 37.2 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
18.0 | 126.1 | GO:0035375 | zymogen binding(GO:0035375) |
17.5 | 157.8 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
17.3 | 86.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
17.3 | 69.1 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
16.8 | 134.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
16.7 | 66.6 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
16.5 | 99.3 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
16.3 | 16.3 | GO:0019003 | GDP binding(GO:0019003) |
16.3 | 48.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
15.4 | 76.8 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
15.3 | 61.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
15.2 | 60.8 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
15.1 | 105.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
15.0 | 44.9 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
14.0 | 70.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
14.0 | 56.0 | GO:0045159 | myosin II binding(GO:0045159) |
14.0 | 41.9 | GO:0004335 | galactokinase activity(GO:0004335) |
13.5 | 80.9 | GO:0019767 | IgE receptor activity(GO:0019767) |
13.4 | 67.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
13.4 | 93.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
13.3 | 26.7 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
13.3 | 133.5 | GO:0019957 | C-C chemokine binding(GO:0019957) |
13.0 | 39.1 | GO:0046980 | peptide antigen-transporting ATPase activity(GO:0015433) tapasin binding(GO:0046980) |
13.0 | 65.1 | GO:0032564 | dATP binding(GO:0032564) |
13.0 | 52.0 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
12.9 | 77.5 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
12.9 | 12.9 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
12.8 | 38.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
12.7 | 38.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
12.7 | 38.0 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
12.7 | 278.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
12.6 | 37.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
12.5 | 50.2 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
12.5 | 62.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
12.4 | 37.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
12.4 | 86.5 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
12.2 | 97.6 | GO:0030274 | LIM domain binding(GO:0030274) |
12.0 | 36.0 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
12.0 | 47.9 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
11.9 | 35.7 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
11.9 | 47.6 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
11.8 | 47.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
11.8 | 106.0 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
11.7 | 199.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
11.7 | 58.4 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
11.7 | 35.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
11.6 | 127.6 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
11.6 | 81.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
11.6 | 57.8 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
11.5 | 46.1 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
11.4 | 57.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
11.4 | 22.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
11.2 | 44.8 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
11.2 | 67.0 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
11.1 | 44.6 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
11.1 | 210.9 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
11.1 | 33.3 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
11.1 | 11.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
11.0 | 209.0 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
11.0 | 43.9 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
10.9 | 293.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
10.7 | 42.7 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
10.7 | 96.0 | GO:0030957 | Tat protein binding(GO:0030957) |
10.5 | 31.6 | GO:0019961 | interferon binding(GO:0019961) |
10.5 | 83.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
10.5 | 83.8 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
10.4 | 31.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
10.4 | 31.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
10.3 | 61.8 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
10.2 | 91.9 | GO:0043515 | kinetochore binding(GO:0043515) |
10.2 | 40.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
10.1 | 30.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
10.0 | 50.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
10.0 | 29.9 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
9.9 | 19.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
9.8 | 78.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
9.7 | 29.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
9.7 | 145.4 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
9.7 | 164.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
9.6 | 57.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
9.5 | 332.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
9.5 | 37.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
9.4 | 47.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
9.3 | 55.9 | GO:0070051 | fibrinogen binding(GO:0070051) |
9.2 | 109.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
9.1 | 146.2 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
9.1 | 18.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
8.9 | 26.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
8.9 | 26.6 | GO:0051425 | PTB domain binding(GO:0051425) |
8.9 | 35.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
8.8 | 17.6 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
8.8 | 26.4 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
8.7 | 43.4 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
8.7 | 52.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
8.7 | 34.6 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
8.6 | 34.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
8.6 | 34.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
8.5 | 25.6 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
8.5 | 34.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
8.5 | 25.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
8.5 | 33.8 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
8.3 | 341.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
8.3 | 16.6 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
8.2 | 24.5 | GO:0005427 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
8.1 | 64.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
8.0 | 72.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
8.0 | 168.1 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
7.9 | 23.8 | GO:0015292 | uniporter activity(GO:0015292) |
7.9 | 86.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
7.7 | 46.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
7.7 | 30.9 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
7.7 | 7.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
7.7 | 23.0 | GO:0000403 | Y-form DNA binding(GO:0000403) |
7.6 | 151.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
7.5 | 60.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
7.5 | 127.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
7.5 | 52.4 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
7.4 | 141.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
7.4 | 22.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
7.2 | 21.7 | GO:0034437 | sterol-transporting ATPase activity(GO:0034041) glycoprotein transporter activity(GO:0034437) |
7.2 | 151.1 | GO:0031996 | thioesterase binding(GO:0031996) |
7.1 | 28.4 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
7.1 | 35.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
7.1 | 91.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
7.0 | 7.0 | GO:0032138 | DNA insertion or deletion binding(GO:0032135) single base insertion or deletion binding(GO:0032138) |
7.0 | 21.0 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
7.0 | 34.9 | GO:0050733 | RS domain binding(GO:0050733) |
7.0 | 76.8 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
7.0 | 118.2 | GO:0043274 | phospholipase binding(GO:0043274) |
6.9 | 69.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
6.9 | 27.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
6.9 | 20.7 | GO:0052723 | inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
6.9 | 41.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
6.8 | 40.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
6.8 | 40.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
6.8 | 338.2 | GO:0031491 | nucleosome binding(GO:0031491) |
6.7 | 13.4 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
6.7 | 80.2 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
6.6 | 65.9 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
6.5 | 6.5 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
6.5 | 84.8 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
6.5 | 13.0 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
6.5 | 13.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
6.5 | 45.5 | GO:0003924 | GTPase activity(GO:0003924) |
6.5 | 329.5 | GO:0004527 | exonuclease activity(GO:0004527) |
6.4 | 19.2 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
6.3 | 38.0 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
6.3 | 50.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
6.2 | 25.0 | GO:0035197 | siRNA binding(GO:0035197) |
6.2 | 37.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
6.2 | 18.6 | GO:0038132 | neuregulin binding(GO:0038132) |
6.0 | 113.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
5.8 | 58.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
5.8 | 17.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
5.8 | 17.3 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
5.7 | 40.2 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
5.7 | 91.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
5.6 | 248.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
5.6 | 16.9 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
5.6 | 139.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
5.6 | 22.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
5.6 | 83.4 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
5.5 | 99.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
5.4 | 358.0 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
5.4 | 53.9 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
5.3 | 101.1 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
5.3 | 237.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
5.3 | 163.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
5.3 | 21.0 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
5.2 | 21.0 | GO:0036310 | annealing helicase activity(GO:0036310) |
5.2 | 36.7 | GO:0048495 | Roundabout binding(GO:0048495) |
5.2 | 15.7 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
5.2 | 10.4 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
5.2 | 15.6 | GO:0000150 | recombinase activity(GO:0000150) |
5.2 | 10.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
5.2 | 36.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
5.2 | 20.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
5.2 | 87.8 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
5.2 | 77.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
5.1 | 128.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
5.1 | 577.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
5.1 | 30.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
5.1 | 30.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
5.1 | 30.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
5.0 | 15.1 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
5.0 | 50.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
5.0 | 15.0 | GO:1990955 | telomerase inhibitor activity(GO:0010521) G-rich single-stranded DNA binding(GO:1990955) |
5.0 | 24.9 | GO:0034452 | dynactin binding(GO:0034452) |
5.0 | 64.4 | GO:0019956 | chemokine binding(GO:0019956) |
4.9 | 800.8 | GO:0042393 | histone binding(GO:0042393) |
4.9 | 98.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
4.9 | 29.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
4.9 | 19.6 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
4.9 | 43.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
4.9 | 43.9 | GO:0042285 | xylosyltransferase activity(GO:0042285) |
4.8 | 9.7 | GO:0055100 | adiponectin binding(GO:0055100) |
4.8 | 58.0 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
4.8 | 23.8 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
4.7 | 37.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
4.7 | 9.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
4.7 | 14.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
4.7 | 121.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
4.7 | 9.3 | GO:0016429 | tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
4.6 | 13.9 | GO:0001605 | adrenomedullin receptor activity(GO:0001605) |
4.6 | 64.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
4.6 | 91.5 | GO:0003678 | DNA helicase activity(GO:0003678) |
4.6 | 36.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
4.6 | 22.9 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
4.6 | 18.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
4.5 | 27.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
4.5 | 18.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
4.5 | 4.5 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
4.5 | 94.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
4.5 | 80.6 | GO:0035173 | histone kinase activity(GO:0035173) |
4.4 | 21.9 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
4.4 | 78.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
4.4 | 143.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
4.3 | 8.7 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
4.3 | 13.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
4.3 | 34.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
4.3 | 47.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
4.3 | 25.9 | GO:0045545 | syndecan binding(GO:0045545) |
4.3 | 12.9 | GO:0034584 | piRNA binding(GO:0034584) |
4.3 | 12.8 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
4.2 | 21.2 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
4.2 | 12.7 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
4.2 | 17.0 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
4.2 | 29.4 | GO:0004064 | arylesterase activity(GO:0004064) |
4.2 | 29.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
4.2 | 8.4 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
4.2 | 12.5 | GO:0031208 | POZ domain binding(GO:0031208) |
4.1 | 24.6 | GO:0098821 | BMP receptor activity(GO:0098821) |
4.1 | 4.1 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
4.0 | 198.2 | GO:0019843 | rRNA binding(GO:0019843) |
4.0 | 16.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
4.0 | 8.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
4.0 | 15.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
4.0 | 19.8 | GO:0070513 | death domain binding(GO:0070513) |
3.9 | 90.4 | GO:0030515 | snoRNA binding(GO:0030515) |
3.9 | 7.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
3.8 | 11.5 | GO:0004522 | ribonuclease A activity(GO:0004522) |
3.8 | 33.8 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
3.7 | 3.7 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
3.7 | 14.9 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
3.7 | 11.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
3.7 | 11.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
3.7 | 22.3 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
3.7 | 54.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
3.5 | 35.4 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
3.5 | 17.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
3.5 | 10.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
3.5 | 7.0 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
3.5 | 21.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
3.5 | 13.9 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
3.5 | 118.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
3.5 | 10.4 | GO:0031720 | haptoglobin binding(GO:0031720) |
3.4 | 13.8 | GO:0004526 | ribonuclease P activity(GO:0004526) |
3.4 | 6.9 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
3.4 | 10.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
3.4 | 10.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
3.4 | 75.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
3.4 | 13.6 | GO:0019002 | GMP binding(GO:0019002) |
3.4 | 27.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
3.3 | 10.0 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
3.3 | 73.2 | GO:0005521 | lamin binding(GO:0005521) |
3.3 | 13.3 | GO:0034061 | DNA polymerase activity(GO:0034061) |
3.3 | 9.9 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
3.3 | 46.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
3.3 | 9.8 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
3.3 | 19.7 | GO:1990446 | U1 snRNP binding(GO:1990446) |
3.2 | 711.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
3.2 | 138.0 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
3.2 | 22.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
3.2 | 9.5 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
3.1 | 12.6 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
3.1 | 74.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
3.1 | 18.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
3.1 | 15.5 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
3.1 | 46.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
3.1 | 24.6 | GO:0005536 | glucose binding(GO:0005536) |
3.1 | 58.0 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
3.0 | 12.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
3.0 | 213.6 | GO:0003777 | microtubule motor activity(GO:0003777) |
3.0 | 3.0 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
2.9 | 29.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
2.9 | 11.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.9 | 26.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
2.9 | 60.8 | GO:0050699 | WW domain binding(GO:0050699) |
2.9 | 11.5 | GO:1990254 | keratin filament binding(GO:1990254) |
2.9 | 54.5 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
2.9 | 5.7 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
2.8 | 39.9 | GO:0019239 | deaminase activity(GO:0019239) |
2.8 | 87.9 | GO:0022829 | wide pore channel activity(GO:0022829) |
2.8 | 8.4 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
2.8 | 39.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
2.7 | 11.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
2.7 | 16.4 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
2.7 | 16.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
2.7 | 38.0 | GO:0070063 | RNA polymerase binding(GO:0070063) |
2.7 | 8.1 | GO:0019863 | IgE binding(GO:0019863) |
2.7 | 16.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
2.7 | 24.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
2.7 | 13.5 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
2.6 | 5.3 | GO:0004775 | succinate-CoA ligase activity(GO:0004774) succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
2.6 | 10.5 | GO:0047619 | acylcarnitine hydrolase activity(GO:0047619) |
2.6 | 7.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
2.6 | 7.7 | GO:0042834 | peptidoglycan binding(GO:0042834) |
2.6 | 7.7 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
2.5 | 71.3 | GO:0004540 | ribonuclease activity(GO:0004540) |
2.5 | 27.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
2.5 | 52.7 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
2.5 | 14.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
2.5 | 12.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
2.5 | 7.4 | GO:0001847 | opsonin receptor activity(GO:0001847) |
2.5 | 12.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
2.5 | 7.4 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
2.4 | 12.2 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
2.4 | 9.7 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
2.4 | 4.8 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
2.4 | 7.2 | GO:0030626 | U12 snRNA binding(GO:0030626) |
2.4 | 19.2 | GO:0016936 | galactoside binding(GO:0016936) |
2.4 | 7.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
2.4 | 16.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
2.4 | 2.4 | GO:0015616 | DNA translocase activity(GO:0015616) |
2.4 | 26.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
2.4 | 37.7 | GO:0001618 | virus receptor activity(GO:0001618) |
2.3 | 4.7 | GO:0030984 | kininogen binding(GO:0030984) |
2.3 | 364.4 | GO:0001047 | core promoter binding(GO:0001047) |
2.3 | 9.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
2.3 | 20.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
2.3 | 6.9 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
2.3 | 16.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
2.3 | 101.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
2.3 | 6.9 | GO:0032027 | myosin light chain binding(GO:0032027) |
2.3 | 13.7 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
2.3 | 9.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
2.3 | 20.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
2.3 | 2.3 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
2.2 | 2.2 | GO:0032427 | GBD domain binding(GO:0032427) |
2.2 | 11.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
2.2 | 35.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
2.2 | 20.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
2.2 | 4.5 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
2.2 | 17.7 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
2.2 | 13.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
2.2 | 88.0 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
2.2 | 2.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
2.2 | 15.2 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
2.2 | 32.4 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
2.2 | 6.5 | GO:0004645 | phosphorylase activity(GO:0004645) |
2.2 | 10.8 | GO:0004104 | cholinesterase activity(GO:0004104) |
2.1 | 21.5 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
2.1 | 40.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
2.1 | 2.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
2.1 | 48.1 | GO:0003823 | antigen binding(GO:0003823) |
2.1 | 64.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
2.0 | 10.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
2.0 | 8.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
2.0 | 6.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
2.0 | 74.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
2.0 | 18.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
2.0 | 10.0 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
2.0 | 39.8 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
2.0 | 17.8 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
2.0 | 7.8 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
1.9 | 3.9 | GO:0046977 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
1.9 | 31.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
1.9 | 7.7 | GO:0035473 | lipase binding(GO:0035473) |
1.9 | 9.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.9 | 15.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
1.9 | 5.7 | GO:0050497 | methylthiotransferase activity(GO:0035596) transferase activity, transferring alkylthio groups(GO:0050497) |
1.9 | 3.8 | GO:0050785 | advanced glycation end-product receptor activity(GO:0050785) |
1.9 | 11.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
1.9 | 138.3 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
1.9 | 54.2 | GO:0034062 | RNA polymerase activity(GO:0034062) |
1.9 | 11.2 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
1.8 | 62.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
1.8 | 2077.2 | GO:0003723 | RNA binding(GO:0003723) |
1.8 | 5.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
1.8 | 23.9 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
1.8 | 12.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
1.8 | 7.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.8 | 10.7 | GO:0004568 | chitinase activity(GO:0004568) |
1.8 | 44.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
1.8 | 73.0 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
1.8 | 1.8 | GO:0050692 | DBD domain binding(GO:0050692) |
1.8 | 8.9 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
1.8 | 24.8 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.8 | 5.3 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
1.8 | 3.5 | GO:0070698 | type I activin receptor binding(GO:0070698) |
1.7 | 15.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.7 | 5.2 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
1.7 | 37.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
1.7 | 22.2 | GO:0003796 | lysozyme activity(GO:0003796) |
1.7 | 8.5 | GO:0070401 | NADP+ binding(GO:0070401) |
1.7 | 207.3 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
1.7 | 37.3 | GO:0001968 | fibronectin binding(GO:0001968) |
1.7 | 23.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
1.7 | 5.1 | GO:0030911 | TPR domain binding(GO:0030911) |
1.7 | 11.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
1.6 | 16.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
1.6 | 6.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.6 | 16.0 | GO:0015926 | glucosidase activity(GO:0015926) |
1.6 | 6.4 | GO:0016972 | thiol oxidase activity(GO:0016972) |
1.6 | 425.9 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
1.6 | 6.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
1.6 | 4.7 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
1.6 | 6.3 | GO:0070728 | leucine binding(GO:0070728) |
1.6 | 4.7 | GO:0015639 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) nickel cation transmembrane transporter activity(GO:0015099) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) chromium ion transmembrane transporter activity(GO:0070835) |
1.5 | 37.0 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
1.5 | 4.6 | GO:0004655 | porphobilinogen synthase activity(GO:0004655) |
1.5 | 12.3 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
1.5 | 3.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
1.5 | 6.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
1.5 | 7.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.5 | 4.5 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
1.5 | 3.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
1.5 | 17.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
1.5 | 2.9 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
1.4 | 15.8 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
1.4 | 200.2 | GO:0051015 | actin filament binding(GO:0051015) |
1.4 | 39.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
1.4 | 10.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.4 | 49.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
1.4 | 2.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
1.4 | 253.9 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
1.4 | 6.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.3 | 4.0 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
1.3 | 32.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
1.3 | 6.7 | GO:0004586 | ornithine decarboxylase activity(GO:0004586) |
1.3 | 20.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
1.3 | 27.8 | GO:0070840 | dynein complex binding(GO:0070840) |
1.3 | 4.0 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
1.3 | 6.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.3 | 14.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
1.3 | 3.8 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.3 | 3.8 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.3 | 16.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
1.3 | 2.5 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
1.3 | 23.9 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
1.3 | 74.1 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
1.3 | 3.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
1.2 | 7.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.2 | 3.6 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
1.2 | 4.9 | GO:0008265 | Mo-molybdopterin cofactor sulfurase activity(GO:0008265) |
1.2 | 256.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
1.2 | 27.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.2 | 2.4 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
1.2 | 972.0 | GO:0003677 | DNA binding(GO:0003677) |
1.2 | 20.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
1.2 | 47.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
1.2 | 11.8 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
1.2 | 25.7 | GO:0043022 | ribosome binding(GO:0043022) |
1.2 | 7.0 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
1.2 | 3.5 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
1.1 | 9.1 | GO:0052744 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
1.1 | 4.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.1 | 100.8 | GO:0008201 | heparin binding(GO:0008201) |
1.1 | 9.8 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
1.1 | 2.2 | GO:0004040 | amidase activity(GO:0004040) |
1.1 | 3.3 | GO:0004359 | glutaminase activity(GO:0004359) |
1.1 | 4.3 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
1.1 | 2.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.1 | 4.3 | GO:0050544 | arachidonic acid binding(GO:0050544) |
1.1 | 4.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
1.1 | 5.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.1 | 6.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.1 | 4.2 | GO:0034711 | inhibin binding(GO:0034711) |
1.1 | 12.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.0 | 5.2 | GO:0038024 | cargo receptor activity(GO:0038024) |
1.0 | 17.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
1.0 | 3.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.0 | 3.0 | GO:0015197 | peptide transporter activity(GO:0015197) |
1.0 | 5.0 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
1.0 | 86.1 | GO:0003712 | transcription cofactor activity(GO:0003712) |
1.0 | 4.0 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
1.0 | 38.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
1.0 | 1.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
1.0 | 32.9 | GO:0004896 | cytokine receptor activity(GO:0004896) |
1.0 | 14.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.0 | 13.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
1.0 | 14.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.9 | 5.6 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.9 | 4.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.9 | 4.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.9 | 27.8 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.9 | 5.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.9 | 2.6 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.9 | 2.6 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.9 | 7.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.9 | 4.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.9 | 24.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.9 | 10.3 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.9 | 1.7 | GO:0055105 | ubiquitin-protein transferase inhibitor activity(GO:0055105) |
0.8 | 2.5 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.8 | 228.2 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.8 | 158.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.8 | 2.5 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.8 | 7.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.8 | 4.7 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.8 | 3.1 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.8 | 350.9 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.8 | 10.7 | GO:0016918 | retinal binding(GO:0016918) |
0.8 | 5.3 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.8 | 29.6 | GO:0015485 | cholesterol binding(GO:0015485) |
0.7 | 4.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.7 | 12.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.7 | 4.9 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.7 | 19.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.7 | 21.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.7 | 7.3 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.7 | 3.3 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.6 | 6.4 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.6 | 6.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.6 | 14.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.6 | 0.6 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.6 | 11.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.5 | 1.6 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.5 | 1.6 | GO:0031770 | growth hormone-releasing hormone receptor binding(GO:0031770) |
0.5 | 1.6 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.5 | 2.6 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.5 | 2.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.5 | 20.0 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.5 | 31.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.5 | 3.6 | GO:0008430 | selenium binding(GO:0008430) |
0.5 | 4.0 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.5 | 2.5 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.5 | 8.4 | GO:0002039 | p53 binding(GO:0002039) |
0.5 | 2.4 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.5 | 1.4 | GO:0016414 | carnitine O-octanoyltransferase activity(GO:0008458) O-octanoyltransferase activity(GO:0016414) |
0.5 | 39.5 | GO:0019902 | phosphatase binding(GO:0019902) |
0.5 | 2.8 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.5 | 1.4 | GO:0032052 | bile acid binding(GO:0032052) |
0.5 | 3.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.5 | 51.4 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.5 | 0.9 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.4 | 1.3 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.4 | 2.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.4 | 4.5 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.4 | 3.9 | GO:0015232 | heme transporter activity(GO:0015232) |
0.4 | 10.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.4 | 2.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.4 | 27.8 | GO:0008565 | protein transporter activity(GO:0008565) |
0.4 | 2.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.4 | 1.2 | GO:0051870 | methotrexate binding(GO:0051870) |
0.4 | 1.2 | GO:0019809 | spermidine binding(GO:0019809) |
0.4 | 9.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.4 | 5.6 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.4 | 2.8 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.3 | 1.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 70.3 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.3 | 13.9 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.3 | 2.3 | GO:0004518 | nuclease activity(GO:0004518) |
0.3 | 92.2 | GO:0005525 | GTP binding(GO:0005525) |
0.3 | 1.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.3 | 0.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.3 | 6.2 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.2 | 1.0 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.2 | 0.2 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.2 | 1.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 2.1 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.2 | 0.8 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 1.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 0.4 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.2 | 0.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 0.9 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 0.6 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.9 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 3.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.9 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.5 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.1 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 1.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.1 | GO:0035004 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) phosphatidylinositol 3-kinase activity(GO:0035004) |
0.0 | 0.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.1 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.0 | 0.0 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.7 | 1099.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
14.5 | 304.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
12.1 | 349.9 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
11.5 | 103.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
11.4 | 537.3 | PID BCR 5PATHWAY | BCR signaling pathway |
10.8 | 184.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
10.6 | 507.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
10.5 | 136.8 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
9.6 | 106.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
9.5 | 66.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
9.1 | 262.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
9.0 | 162.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
8.8 | 201.6 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
8.5 | 389.1 | PID AURORA B PATHWAY | Aurora B signaling |
8.2 | 74.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
8.1 | 16.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
7.9 | 86.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
7.7 | 269.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
7.5 | 351.9 | PID PLK1 PATHWAY | PLK1 signaling events |
7.4 | 221.8 | PID BARD1 PATHWAY | BARD1 signaling events |
7.3 | 145.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
7.1 | 164.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
6.8 | 34.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
6.7 | 86.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
6.6 | 132.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
6.6 | 118.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
6.4 | 244.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
6.4 | 12.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
6.2 | 93.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
6.2 | 290.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
6.1 | 42.5 | PID EPO PATHWAY | EPO signaling pathway |
6.0 | 90.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
6.0 | 36.0 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
5.5 | 205.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
5.5 | 143.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
5.5 | 16.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
5.4 | 97.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
5.4 | 21.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
5.2 | 261.4 | PID E2F PATHWAY | E2F transcription factor network |
4.8 | 33.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
4.6 | 83.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
4.6 | 110.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
4.5 | 22.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
4.3 | 94.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
4.3 | 55.7 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
4.2 | 71.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
4.2 | 79.3 | PID MYC PATHWAY | C-MYC pathway |
4.2 | 87.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
4.1 | 40.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
4.0 | 125.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
4.0 | 127.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
4.0 | 27.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
3.9 | 236.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
3.8 | 64.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
3.6 | 102.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
3.6 | 86.9 | PID RHOA PATHWAY | RhoA signaling pathway |
3.6 | 54.0 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
3.6 | 10.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
3.5 | 161.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
3.5 | 128.4 | PID P53 REGULATION PATHWAY | p53 pathway |
3.3 | 52.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
3.2 | 45.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
3.2 | 31.8 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
3.1 | 27.9 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
3.0 | 3.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
2.9 | 66.3 | PID ALK1 PATHWAY | ALK1 signaling events |
2.8 | 41.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
2.7 | 80.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
2.7 | 29.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
2.6 | 7.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
2.5 | 61.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
2.4 | 14.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
2.4 | 14.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
2.3 | 56.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
2.3 | 78.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
2.3 | 64.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
2.3 | 22.8 | PID ATR PATHWAY | ATR signaling pathway |
2.3 | 88.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
2.2 | 196.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
2.2 | 4.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
2.1 | 14.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
2.1 | 24.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
2.0 | 9.9 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.9 | 7.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.9 | 26.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
1.9 | 9.4 | PID IFNG PATHWAY | IFN-gamma pathway |
1.9 | 40.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.7 | 10.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
1.7 | 48.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.7 | 31.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
1.6 | 37.8 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
1.6 | 48.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
1.5 | 11.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
1.4 | 19.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
1.3 | 49.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
1.2 | 16.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
1.2 | 17.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.2 | 3.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
1.2 | 35.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
1.2 | 2.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.1 | 10.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
1.1 | 5.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
1.1 | 12.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
1.1 | 43.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
1.1 | 13.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.0 | 25.1 | PID ENDOTHELIN PATHWAY | Endothelins |
1.0 | 8.8 | PID AURORA A PATHWAY | Aurora A signaling |
1.0 | 9.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
1.0 | 40.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.9 | 14.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.9 | 176.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.9 | 4.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.9 | 6.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.8 | 2.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.7 | 6.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.7 | 0.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.6 | 15.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.6 | 4.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.5 | 21.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.5 | 4.0 | ST ADRENERGIC | Adrenergic Pathway |
0.5 | 3.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.4 | 6.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 2.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.3 | 5.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 3.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 1.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.6 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 1.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
42.7 | 341.8 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
33.3 | 133.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
28.8 | 57.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
24.8 | 149.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
23.3 | 279.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
21.3 | 21.3 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
20.8 | 20.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
19.3 | 289.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
17.6 | 17.6 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
15.4 | 168.9 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
15.2 | 259.1 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
15.1 | 105.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
15.0 | 30.0 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
14.0 | 266.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
13.9 | 152.8 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
13.6 | 611.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
12.4 | 694.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
12.4 | 384.0 | REACTOME KINESINS | Genes involved in Kinesins |
12.1 | 399.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
11.7 | 140.2 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
11.7 | 128.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
10.7 | 10.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
10.7 | 85.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
10.7 | 192.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
10.5 | 73.8 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
9.4 | 131.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
9.1 | 54.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
9.0 | 9.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
8.9 | 142.8 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
8.9 | 231.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
8.7 | 86.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
8.5 | 162.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
8.5 | 526.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
8.1 | 105.9 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
7.9 | 31.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
7.8 | 85.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
7.8 | 124.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
7.8 | 131.8 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
7.4 | 29.5 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
7.3 | 65.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
7.2 | 281.6 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
7.2 | 64.8 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
7.1 | 278.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
7.1 | 298.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
7.1 | 141.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
7.1 | 98.7 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
6.9 | 111.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
6.9 | 55.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
6.9 | 158.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
6.9 | 61.9 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
6.8 | 74.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
6.8 | 74.9 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
6.8 | 136.0 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
6.7 | 26.7 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
6.6 | 502.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
6.4 | 70.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
6.2 | 149.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
6.1 | 73.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
6.1 | 145.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
6.0 | 23.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
5.9 | 453.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
5.5 | 22.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
5.2 | 103.8 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
5.1 | 10.1 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
5.0 | 114.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
4.9 | 93.7 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
4.8 | 63.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
4.8 | 38.2 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
4.5 | 199.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
4.5 | 94.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
4.5 | 44.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
4.4 | 62.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
4.3 | 43.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
4.2 | 25.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
4.2 | 8.4 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
4.2 | 41.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
4.1 | 4.1 | REACTOME HIV INFECTION | Genes involved in HIV Infection |
4.0 | 40.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
3.9 | 161.8 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
3.9 | 15.7 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
3.9 | 62.6 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
3.9 | 23.4 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
3.8 | 37.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
3.8 | 33.8 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
3.7 | 48.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
3.7 | 40.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
3.6 | 40.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
3.6 | 65.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
3.4 | 43.9 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
3.4 | 23.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
3.3 | 120.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
3.3 | 107.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
3.2 | 70.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
3.2 | 436.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
3.2 | 12.6 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
3.2 | 44.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
3.1 | 6.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
3.1 | 198.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
3.0 | 21.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
3.0 | 3.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
3.0 | 11.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
2.9 | 128.7 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
2.9 | 23.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
2.8 | 51.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
2.7 | 8.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
2.6 | 78.9 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
2.6 | 28.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
2.5 | 37.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
2.4 | 41.0 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
2.4 | 40.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
2.4 | 33.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
2.3 | 30.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
2.3 | 9.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
2.2 | 75.6 | REACTOME TRANSLATION | Genes involved in Translation |
2.1 | 21.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
2.1 | 148.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
2.1 | 168.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
2.1 | 2.1 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
2.0 | 8.2 | REACTOME DEFENSINS | Genes involved in Defensins |
2.0 | 30.3 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
2.0 | 44.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
2.0 | 7.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
2.0 | 27.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.9 | 17.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
1.8 | 5.3 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
1.7 | 77.2 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
1.6 | 16.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
1.6 | 17.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
1.6 | 22.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
1.6 | 46.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
1.5 | 3.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
1.5 | 24.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.4 | 15.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
1.4 | 23.8 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
1.4 | 20.5 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
1.4 | 34.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
1.3 | 6.7 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
1.3 | 9.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
1.3 | 2.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.2 | 12.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
1.2 | 11.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
1.1 | 26.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.1 | 21.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
1.0 | 15.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
1.0 | 8.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
1.0 | 53.4 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
1.0 | 18.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
1.0 | 30.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.8 | 4.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.8 | 3.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.7 | 22.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.7 | 2.9 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.7 | 15.3 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.7 | 7.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.7 | 3.5 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.7 | 5.6 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.7 | 4.2 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.7 | 5.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.7 | 11.1 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.6 | 7.6 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.6 | 24.7 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.6 | 5.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.6 | 9.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.5 | 10.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.5 | 1.5 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.5 | 9.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.4 | 1.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.4 | 13.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.4 | 12.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.4 | 6.8 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.4 | 15.2 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.4 | 4.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.4 | 1.8 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.4 | 0.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.3 | 8.0 | REACTOME ACTIVATED TLR4 SIGNALLING | Genes involved in Activated TLR4 signalling |
0.3 | 6.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 1.9 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 4.8 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.2 | 2.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 3.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 3.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 3.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 3.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 0.2 | REACTOME HIV LIFE CYCLE | Genes involved in HIV Life Cycle |
0.0 | 0.5 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.5 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |